Bradley F. Boeve
#90,560
Most Influential Person Now
Bradley F. Boeve's AcademicInfluence.com Rankings
Bradley F. Boevemedical Degrees
Medical
#947
World Rank
#1220
Historical Rank
Neurology
#84
World Rank
#133
Historical Rank
Download Badge
Medical
Bradley F. Boeve's Degrees
- Doctorate Medicine University of Iowa
Why Is Bradley F. Boeve Influential?
(Suggest an Edit or Addition)Bradley F. Boeve's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS (2011) (4089)
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. (2011) (3651)
- Classification of primary progressive aphasia and its variants (2011) (3469)
- Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 (2006) (1809)
- Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) (1656)
- Diagnosis and management of dementia with Lewy bodies (2017) (1606)
- Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment (1999) (1373)
- Mild cognitive impairment: ten years later. (2009) (1265)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
- Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease (2009) (1017)
- 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. (2008) (876)
- Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. (2007) (860)
- Rates of hippocampal atrophy correlate with change in clinical status in aging and AD (2000) (845)
- Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD (2004) (785)
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
- Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. (2013) (633)
- Neuropathology of Cognitively Normal Elderly (2003) (629)
- The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics (2008) (619)
- Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. (2006) (602)
- Neuropathologic features of amnestic mild cognitive impairment. (2006) (589)
- Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia (2002) (564)
- An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease (2012) (560)
- Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy (2004) (552)
- 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. (2007) (544)
- Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy (2001) (541)
- Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. (2006) (539)
- REM sleep behavior disorder (2010) (535)
- Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia (2003) (492)
- Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI (2005) (482)
- Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study (2019) (482)
- Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions (2010) (475)
- Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease (2000) (465)
- Steroid-responsive encephalopathy associated with autoimmune thyroiditis. (2006) (456)
- Alzheimer's disease diagnosis in individual subjects using structural MR images: Validation studies (2008) (452)
- Mutations in the colony stimulating factor 1 receptor (CSF1R) cause hereditary diffuse leukoencephalopathy with spheroids (2011) (442)
- Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis (2008) (433)
- Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP (2006) (423)
- Memory and MRI-based hippocampal volumes in aging and AD (2000) (412)
- Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody (2004) (398)
- Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD (2000) (397)
- Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. (2002) (392)
- Non-Stationarity in the “Resting Brain’s” Modular Architecture (2012) (386)
- Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis (2018) (384)
- An autoradiographic evaluation of AV-1451 Tau PET in dementia (2016) (383)
- Cascading network failure across the Alzheimer’s disease spectrum (2015) (377)
- Physical exercise, aging, and mild cognitive impairment: a population-based study. (2010) (374)
- Association of Low Plasma Aβ42/Aβ40 Ratios With Increased Imminent Risk for Mild Cognitive Impairment and Alzheimer Disease (2007) (373)
- Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics (2012) (372)
- Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study. (2008) (369)
- Lewy body dementias (2015) (366)
- Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism (2003) (356)
- Assessing the temporal relationship between cognition and gait: slow gait predicts cognitive decline in the Mayo Clinic Study of Aging. (2013) (352)
- DLB and PDD boundary issues (2007) (351)
- Consensus classification of posterior cortical atrophy (2017) (350)
- Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members (2009) (348)
- Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. (2003) (345)
- Comparison of memory fMRI response among normal, MCI, and Alzheimer’s patients (2003) (343)
- Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 (2012) (341)
- MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment (2008) (340)
- Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study (2012) (336)
- MRI correlates of neurofibrillary tangle pathology at autopsy (2008) (335)
- Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. (2008) (331)
- Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging (2015) (329)
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration (2020) (322)
- Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. (2001) (318)
- Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal (2014) (317)
- TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease (2013) (311)
- Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. (2006) (310)
- Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. (2013) (307)
- TDP-43 is a key player in the clinical features associated with Alzheimer’s disease (2014) (307)
- REM sleep behavior disorder and degenerative dementia (1998) (305)
- Brain β-amyloid load approaches a plateau (2013) (300)
- Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. (2007) (294)
- Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia (2008) (289)
- Common variants at MS 4 A 4 / MS 4 A 6 E , CD 2 AP , CD 33 and EPHA 1 are associated with late-onset Alzheimer ’ s disease (2011) (274)
- Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families (2012) (270)
- Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. (2009) (263)
- Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS (2014) (262)
- Frontotemporal dementia and its subtypes: a genome-wide association study (2014) (262)
- Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease (2015) (255)
- DLB fluctuations (2004) (249)
- Association of traumatic brain injury with subsequent neurological and psychiatric disease: a meta-analysis. (2016) (244)
- Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort. (2011) (242)
- 11 C PiB and structural MRI provide complementary information in imaging of Alzheimer ’ s disease and amnestic mild cognitive impairment (2008) (240)
- Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study (2013) (235)
- Research criteria for the diagnosis of prodromal dementia with Lewy bodies (2020) (232)
- DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment (2005) (231)
- Incidence of dementia with Lewy bodies and Parkinson disease dementia. (2013) (230)
- Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study. (2014) (230)
- Mild cognitive impairment due to Alzheimer disease in the community (2013) (228)
- Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease (2012) (227)
- Chronic traumatic encephalopathy pathology in a neurodegenerative disorders brain bank (2015) (227)
- Association of duration and severity of diabetes mellitus with mild cognitive impairment. (2008) (226)
- Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson’s disease over time (2007) (219)
- Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. (2006) (219)
- Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype (2008) (219)
- Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative (2007) (218)
- 1H MR spectroscopy in common dementias (2004) (217)
- β‐amyloid burden is not associated with rates of brain atrophy (2008) (216)
- REM Sleep Behavior Disorder in Parkinson’s Disease and Dementia with Lewy Bodies (2004) (215)
- Voxel-based morphometry in autopsy proven PSP and CBD (2008) (214)
- Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. (2003) (210)
- Effect of APOE ε4 status on intrinsic network connectivity in cognitively normal elderly subjects. (2011) (209)
- Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. (2012) (208)
- TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers (2010) (208)
- Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family (2010) (208)
- Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment. (2003) (203)
- Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. (2007) (202)
- Autonomic dysfunction in dementia with Lewy bodies (2004) (197)
- Patterns of atrophy differ among specific subtypes of mild cognitive impairment. (2007) (195)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2019) (194)
- Antemortem diagnosis of frontotemporal lobar degeneration (2005) (194)
- A Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas: The Impact of the Extent of Resection on Quality of Life and Survival (2005) (193)
- Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease (2007) (190)
- Vascular dementia in a population-based autopsy study. (2003) (189)
- Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. (2010) (188)
- Comparison of 18F-FDG and PiB PET in Cognitive Impairment (2009) (188)
- Imaging correlates of pathology in corticobasal syndrome (2010) (187)
- Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. (2013) (187)
- Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia. (2018) (186)
- Paraneoplastic chorea associated with CRMP‐5 neuronal antibody and lung carcinoma (2002) (186)
- Imaging correlates of posterior cortical atrophy (2007) (185)
- Neuropsychological Differentiation of Dementia with Lewy Bodies from Normal Aging and Alzheimer's Disease (2006) (184)
- Association of type 2 diabetes with brain atrophy and cognitive impairment (2014) (183)
- Treatment outcomes in REM sleep behavior disorder. (2013) (182)
- Multimodality imaging characteristics of dementia with Lewy bodies (2012) (180)
- Neuropathologic Features of Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions With Progranulin Gene (PGRN) Mutations (2007) (180)
- Atrophy rates accelerate in amnestic mild cognitive impairment (2008) (178)
- Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: A population‐based study (2012) (176)
- Prominent phenotypic variability associated with mutations in Progranulin (2009) (176)
- Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies (2013) (175)
- Clinical presentation and pharmacological therapy in corticobasal degeneration. (1998) (174)
- Brain injury biomarkers are not dependent on β‐amyloid in normal elderly (2013) (173)
- REM sleep behaviour disorder (2018) (172)
- Clinical spectrum of voltage-gated potassium channel autoimmunity (2008) (171)
- Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas (2006) (170)
- Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage (2008) (168)
- Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. (2008) (166)
- Ataxin-2 repeat-length variation and neurodegeneration. (2011) (164)
- Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia (2005) (164)
- Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study (2018) (163)
- CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia (2016) (160)
- Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease (2013) (159)
- Comparative Diagnostic Utility of Different MR Modalities in Mild Cognitive Impairment and Alzheimer’s Disease (2002) (158)
- Effect of lifestyle activities on alzheimer disease biomarkers and cognition (2012) (158)
- Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. (2007) (157)
- Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy (2015) (157)
- Autoimmune dementia: clinical course and predictors of immunotherapy response. (2010) (155)
- Rates of cerebral atrophy differ in different degenerative pathologies. (2006) (154)
- Validation of the Neuropathologic Criteria of the Third Consortium for Dementia With Lewy Bodies for Prospectively Diagnosed Cases (2008) (150)
- Progressive aphasia secondary to Alzheimer disease vs FTLD pathology (2008) (146)
- APOE modifies the association between Aβ load and cognition in cognitively normal older adults (2012) (146)
- Diffusion tensor imaging and cognitive function in older adults with no dementia (2011) (145)
- Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). (2008) (145)
- Indicators of amyloid burden in a population-based study of cognitively normal elderly (2012) (144)
- Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. (2014) (140)
- Frequency of tau mutations in three series of non‐Alzheimer's degenerative dementia (1999) (140)
- The chromosome 9 ALS and FTD locus is probably derived from a single founder (2012) (139)
- Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures (2015) (139)
- Vegetables, Unsaturated Fats, Moderate Alcohol Intake, and Mild Cognitive Impairment (2010) (139)
- Association of diabetes with amnestic and nonamnestic mild cognitive impairment (2014) (138)
- AV‐1451 tau and β‐amyloid positron emission tomography imaging in dementia with Lewy bodies (2016) (137)
- Two distinct subtypes of right temporal variant frontotemporal dementia (2009) (136)
- Dementia with Lewy bodies and Alzheimer disease (2010) (135)
- Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum (2017) (133)
- Melatonin therapy for REM sleep behavior disorder: a critical review of evidence. (2015) (132)
- Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies? (2011) (131)
- Diabetes and Elevated Hemoglobin A1c Levels Are Associated with Brain Hypometabolism but Not Amyloid Accumulation (2014) (130)
- Rapidly progressive neurodegenerative dementias. (2009) (130)
- White-matter integrity on DTI and the pathologic staging of Alzheimer's disease (2017) (130)
- Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease (2008) (129)
- Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN (2009) (129)
- EEG findings in steroid-responsive encephalopathy associated with autoimmune thyroiditis (2003) (129)
- Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study (2019) (128)
- TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia (2014) (127)
- Paroxysmal sympathetic storms ("diencephalic seizures") after severe diffuse axonal head injury. (1998) (126)
- Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research (2012) (126)
- REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies (2017) (126)
- Shapes of the trajectories of 5 major biomarkers of Alzheimer disease. (2012) (126)
- Atypical Progressive Supranuclear Palsy With Corticospinal Tract Degeneration (2006) (125)
- α-Synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals (2006) (123)
- Practice Effects and Longitudinal Cognitive Change in Normal Aging vs. Incident Mild Cognitive Impairment and Dementia in The Mayo Clinic Study of Aging (2013) (122)
- Association of Excessive Daytime Sleepiness With Longitudinal &bgr;-Amyloid Accumulation in Elderly Persons Without Dementia (2018) (121)
- Diagnostic Utility of Letter Fluency, Category Fluency, and Fluency Difference Scores in Alzheimer's Disease (2002) (120)
- Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in a community-based sample. (2013) (117)
- New evidence on the management of Lewy body dementia (2020) (116)
- Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T. (2003) (116)
- REM Sleep Behavior Disorder and REM Sleep Without Atonia as an Early Manifestation of Degenerative Neurological Disease (2012) (115)
- Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. (2010) (114)
- Frequency and Correlates of Caregiver‐Reported Sleep Disturbances in a Sample of Persons with Early Dementia (2010) (113)
- Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies (2015) (113)
- Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations (2002) (111)
- Young-onset dementia: demographic and etiologic characteristics of 235 patients. (2008) (111)
- De novo genesis of neuropsychiatric symptoms in Mild Cognitive Impairment (MCI) (2004) (111)
- REM sleep behavior disorder and dementia (1999) (110)
- Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders. (2020) (110)
- Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts (2016) (110)
- Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status. (2002) (110)
- Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome (2005) (110)
- Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study. (2006) (109)
- Temporoparietal atrophy: A marker of AD pathology independent of clinical diagnosis (2011) (108)
- TDP-43 represses cryptic exon inclusion in the FTD–ALS gene UNC13A (2021) (108)
- Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study (2021) (107)
- Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images (2015) (107)
- Rarity of encephalopathy associated with autoimmune thyroiditis: a case series from Mayo Clinic from 1950 to 1996. (2002) (106)
- Early Alzheimer's Disease Neuropathology Detected by Proton MR Spectroscopy (2014) (106)
- Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART) (2017) (105)
- 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease (2002) (105)
- Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome (2009) (105)
- C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease. (2013) (105)
- Association of C-reactive protein with mild cognitive impairment (2009) (104)
- A Presenilin 1 Mutation Associated with Familial Frontotemporal Dementia Inhibits γ-Secretase Cleavage of APP and Notch (2002) (103)
- Dementia with Lewy bodies (2014) (102)
- Mutations in progranulin explain atypical phenotypes with variants in MAPT. (2006) (102)
- The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes (2019) (102)
- Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. (2011) (102)
- REM Sleep Behavior Disorder: Diagnosis, Clinical Implications, and Future Directions (2017) (102)
- Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72 (2015) (101)
- Rapid eye movement sleep behavior disorder and subtypes in autopsy‐confirmed dementia with Lewy bodies (2012) (100)
- 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons (2014) (100)
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture (2021) (99)
- Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. (2011) (97)
- Engaging in cognitive activities, aging, and mild cognitive impairment: a population-based study. (2011) (97)
- Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND (2011) (97)
- APOE ε4 is associated with severity of Lewy body pathology independent of Alzheimer pathology (2018) (96)
- Antidepressants Increase REM Sleep Muscle Tone in Patients with and without REM Sleep Behavior Disorder. (2015) (93)
- Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers (2015) (93)
- REM sleep behavior disorder initiated by acute brainstem multiple sclerosis (2006) (92)
- Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype (2012) (92)
- Delayed emergence of a parkinsonian disorder or dementia in 81% of older males initially diagnosed with idiopathic REM sleep behavior disorder (RBD): 16 year update on a previously reported series (2013) (91)
- Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy. (1999) (91)
- Caudate atrophy on MRI is a characteristic feature of FTLD‐FUS (2010) (90)
- Survival profiles of patients with frontotemporal dementia and motor neuron disease. (2009) (89)
- Metabolic Syndrome, Inflammation, and Nonamnestic Mild Cognitive Impairment in Older Persons: A Population-based Study (2010) (89)
- Risk factors for dementia with Lewy bodies (2013) (89)
- Diagnostic thresholds for quantitative REM sleep phasic burst duration, phasic and tonic muscle activity, and REM atonia index in REM sleep behavior disorder with and without comorbid obstructive sleep apnea. (2014) (89)
- Tau-positron emission tomography correlates with neuropathology findings (2019) (88)
- The anatomic correlate of prosopagnosia in semantic dementia (2008) (88)
- Shining a light on posterior cortical atrophy (2013) (87)
- Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease (2016) (86)
- Risk of dementia in MCI (2009) (85)
- C9ORF72 repeat expansions in cases with previously identified pathogenic mutations (2013) (85)
- MRI and MRS predictors of mild cognitive impairment in a population-based sample (2013) (84)
- Testing normal older people three or four times at 1- to 2-year intervals: defining normal variance. (1999) (84)
- Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes. (2008) (84)
- Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study (2018) (83)
- Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. (2007) (83)
- 3 D maps frommultiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer ’ s disease (2007) (83)
- Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers (2014) (82)
- Association of prior stroke with cognitive function and cognitive impairment: a population-based study. (2009) (82)
- A population-based study of the association between bullous pemphigoid and neurologic disorders. (2014) (82)
- Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. (2018) (81)
- Involvement of medullary regions controlling sympathetic output in Lewy body disease. (2004) (80)
- Frontotemporal Dementia Treatment: Current Symptomatic Therapies and Implications of Recent Genetic, Biochemical, and Neuroimaging Studies (2007) (79)
- TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia (2013) (79)
- The Multiple Phenotypes of Corticobasal Syndrome and Corticobasal Degeneration: Implications for Further Study (2011) (79)
- Familial Frontotemporal Dementia Associated with a Novel Presenilin-1 Mutation (2002) (78)
- Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND (2005) (78)
- A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (2019) (77)
- Frontotemporal dementia with the V337M MAPT mutation (2017) (77)
- Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration? (2010) (76)
- Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year (2009) (76)
- Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. (2011) (76)
- Diagnostic accuracy of four approaches to interpreting neuropsychological test data. (2000) (75)
- Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy (2019) (74)
- Sleep Disturbance in Dementia with Lewy Bodies and Alzheimer’s Disease: A Multicenter Analysis (2011) (74)
- Nonstationarity in the ‘resting brain's’ modular architecture (2012) (73)
- Mild cognitive impairment in the oldest old (2003) (73)
- Polysomnographic Findings in Dementia With Lewy Bodies (2013) (72)
- Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with β-amyloidosis. (2013) (72)
- A plateau in pre-Alzheimer memory decline (2007) (72)
- Factors associated with injury in REM sleep behavior disorder. (2014) (72)
- Ante mortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies (2012) (71)
- Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. (2004) (71)
- Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration (2014) (71)
- Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies (2012) (71)
- The treatment of parasomnias with hypnosis: a 5-year follow-up study. (2007) (70)
- Cardiac disease associated with increased risk of nonamnestic cognitive impairment: stronger effect on women. (2013) (69)
- Progressive Nonfluent Aphasia and Subsequent Aphasic Dementia Associated with Atypical Progressive Supranuclear Palsy Pathology (2003) (68)
- Excessive daytime sleepiness and fatigue may indicate accelerated brain aging in cognitively normal late middle-aged and older adults. (2017) (68)
- Probable RBD is increased in Parkinson's disease but not in essential tremor or restless legs syndrome. (2011) (68)
- In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers (2017) (68)
- Association of hypometabolism and amyloid levels in aging, normal subjects (2014) (68)
- Anatomical differences between CBS‐corticobasal degeneration and CBS‐Alzheimer's disease (2010) (68)
- Computer activities, physical exercise, aging, and mild cognitive impairment: a population-based study. (2012) (67)
- Lewy body variant of alzheimer's disease (AD) identified by postmortem ubiquitin staining in a previously reported case of AD associated with REM sleep behavior disorder (1997) (67)
- TYROBP genetic variants in early-onset Alzheimer's disease (2016) (67)
- Imaging Signatures of Molecular Pathology in Behavioral Variant Frontotemporal Dementia (2011) (67)
- High School Football and Late‐Life Risk of Neurodegenerative Syndromes, 1956–1970 (2017) (67)
- Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging. (2012) (67)
- Argyrophilic grains: A distinct disease or an additive pathology? (2008) (67)
- Visual hallucinations in posterior cortical atrophy. (2006) (67)
- Progranulin protein levels are differently regulated in plasma and CSF (2014) (66)
- Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease (2018) (66)
- Neuropathological analysis of brainstem cholinergic and catecholaminergic nuclei in relation to rapid eye movement (REM) sleep behaviour disorder (2012) (66)
- Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE) (2003) (66)
- Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies. (2012) (65)
- Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease. (2006) (65)
- Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations (2009) (64)
- Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD (2019) (63)
- Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene (2014) (62)
- Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. (2020) (62)
- Alzheimer disease-like phenotype associated with the c.154delA mutation in progranulin. (2010) (62)
- Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study (2017) (62)
- Comparison of Gait Parameters for Predicting Cognitive Decline: The Mayo Clinic Study of Aging. (2016) (62)
- Entorhinal cortex tau, amyloid-&bgr;, cortical thickness and memory performance in non-demented subjects (2019) (62)
- Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies. (2016) (61)
- Progressive dysexecutive syndrome due to Alzheimer’s disease: a description of 55 cases and comparison to other phenotypes (2020) (61)
- Neuropsychological assessment of patients with dementing illness (2011) (60)
- CHMP2B mutations are not a common cause of frontotemporal lobar degeneration (2006) (60)
- Spectrum of cognition short of dementia (2015) (59)
- Characterization of DCTN1 genetic variability in neurodegeneration (2009) (59)
- Risk and protective factors for cognitive impairment in persons aged 85 years and older (2015) (59)
- Narcolepsy associated with other central nervous system disorders (2001) (59)
- ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans (2018) (59)
- The alien limb phenomenon (2013) (59)
- FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis (2018) (58)
- Arguing against the proposed definition changes of PD (2016) (58)
- Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials (2019) (57)
- Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology (2013) (57)
- In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms (2018) (56)
- Effects of ApoE genotype and mild cognitive impairment on implicit learning (2007) (56)
- Understanding the Diagnostic Capabilities of Cognitive Tests (2001) (56)
- [18F]AV‐1451 tau‐PET and primary progressive aphasia (2018) (56)
- MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies (2013) (56)
- Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium (2020) (56)
- Frontal asymmetry in behavioral variant frontotemporal dementia: clinicoimaging and pathogenetic correlates (2013) (56)
- [18F]AV‐1451 clustering of entorhinal and cortical uptake in Alzheimer's disease (2018) (55)
- Mayo's Older Americans Normative Studies: Visual Form Discrimination and copy trial of the Rey–Osterrieth Complex Figure (2007) (55)
- Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders (2015) (55)
- Hypothyroidism and risk of mild cognitive impairment in elderly persons: a population-based study. (2014) (55)
- Current management of sleep disturbances in dementia (2002) (55)
- Symmetric corticobasal degeneration (S-CBD). (2010) (54)
- Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies. (2020) (54)
- Association of Apolipoprotein E &egr;4 With Transactive Response DNA-Binding Protein 43 (2018) (53)
- Mild cognitive impairment associated with underlying Alzheimer's disease versus Lewy body disease. (2012) (53)
- The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies (2018) (53)
- Magnetic resonance elastography of frontotemporal dementia (2015) (53)
- REM Sleep Behavior Disorder : Updated Review of the Core Features , the RBD-Neurodegenerative Disease Association , Evolving Concepts , Controversies , and Future Directions (2010) (53)
- Polygenic risk scores in familial Alzheimer disease (2017) (52)
- Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease (2004) (52)
- Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction (2018) (52)
- Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic (2021) (52)
- Rates of brain atrophy over time in autopsy-proven frontotemporal dementia and Alzheimer disease (2008) (51)
- Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS (2008) (50)
- Association between contact sports participation and chronic traumatic encephalopathy: a retrospective cohort study (2019) (50)
- Antemortem MRI findings associated with microinfarcts at autopsy (2014) (50)
- Subtle gait changes in patients with REM sleep behavior disorder (2013) (50)
- MR Elastography Demonstrates Unique Regional Brain Stiffness Patterns in Dementias. (2017) (50)
- Predicting future rates of tau accumulation on PET (2020) (50)
- Links Between Frontotemporal Lobar Degeneration, Corticobasal Degeneration, Progressive Supranuclear Palsy, and Amyotrophic Lateral Sclerosis (2007) (50)
- Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults (2019) (49)
- Predicting functional decline in behavioural variant frontotemporal dementia. (2011) (49)
- The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier) (2013) (49)
- Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation. (2005) (49)
- A preliminary fluorodeoxyglucose positron emission tomography study in healthy adults reporting dream-enactment behavior. (2006) (49)
- Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzhei (2014) (48)
- MRI Correlates of Protein Deposition and Disease Severity in Postmortem Frontotemporal Lobar Degeneration (2009) (48)
- Frontotemporal Dementia Mimicking Dementia With Lewy Bodies (2008) (48)
- Argyrophilic Grain Disease in Demented Subjects Presenting Initially With Amnestic Mild Cognitive Impairment (2006) (48)
- DEMENTIA WITH LEWY BODIES (2004) (47)
- Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD (2014) (47)
- Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder (2021) (47)
- A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies (2019) (47)
- No association between TAU haplotype and Alzheimer's disease in population or clinic based series or in familial disease (2000) (47)
- Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects?☆ (2013) (47)
- The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease. (2016) (46)
- MRS in presymptomatic MAPT mutation carriers (2010) (46)
- Diagnostic REM sleep muscle activity thresholds in patients with idiopathic REM sleep behavior disorder with and without obstructive sleep apnea. (2017) (45)
- Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations (2011) (44)
- Age-at-Onset in Late Onset Alzheimer Disease is Modified by Multiple Genetic Loci (2014) (44)
- Abnormal daytime sleepiness in dementia with Lewy bodies compared to Alzheimer’s disease using the Multiple Sleep Latency Test (2014) (44)
- Plasma sphingolipid changes with autopsy-confirmed Lewy body or Alzheimer's pathology (2016) (44)
- Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). (2007) (44)
- Duration and Pathologic Correlates of Lewy Body Disease (2017) (43)
- Sleep Disturbances in Frontotemporal Dementia (2016) (42)
- Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype (2018) (42)
- Hippocampal volumes predict risk of dementia with Lewy bodies in mild cognitive impairment (2015) (41)
- Predicting Survival in Dementia With Lewy Bodies With Hippocampal Volumetry (2016) (41)
- The effect of tau genotype on clinical features in FTDP-17. (2005) (41)
- Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium (2019) (41)
- An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease (2017) (41)
- Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2020) (40)
- Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies (2014) (40)
- Coexistent Lewy body disease in a case of “visual variant of Alzheimer’s disease” (2003) (40)
- Depressive and anxiety symptoms and cortical amyloid deposition among cognitively normal elderly persons: the Mayo Clinic Study of Aging (2017) (40)
- Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder. (2020) (40)
- Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases (2020) (40)
- Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS (2014) (39)
- Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes. (2020) (39)
- Rarity of the Alzheimer disease-protective APP A673T variant in the United States. (2015) (39)
- The "eye-of-the-tiger" sign is not pathognomonic of the PANK2 mutation. (2006) (39)
- A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotes. (2002) (38)
- Long-Term Locomotor Training for Gait and Balance in a Patient With Mixed Progressive Supranuclear Palsy and Corticobasal Degeneration (2007) (38)
- Lesional REM sleep behavior disorder localizes to the dorsomedial pons (2014) (38)
- Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. (2007) (37)
- Cognitive measures predict pathologic Alzheimer disease. (2006) (37)
- β-Amyloid PET and neuropathology in dementia with Lewy bodies (2019) (37)
- The strong presence of REM sleep behavior disorder in PD (2011) (37)
- Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease. (2009) (37)
- Neuropsychiatric aspects of primary progressive aphasia. (2011) (37)
- Dementia with Lewy bodies. (2007) (37)
- Corticobasal Degeneration and Frontotemporal Dementia Presentations in a Kindred with Nonspecific Histopathology (2002) (36)
- What is the quality of life in the oldest old? (2011) (36)
- Fine‐Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies (2020) (36)
- Associations of quantitative susceptibility mapping with Alzheimer’s disease clinical and imaging markers (2020) (35)
- Polka music and semantic dementia (2001) (35)
- Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease (2019) (35)
- New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures (2019) (35)
- REM sleep muscle activity in idiopathic REM sleep behavior disorder predicts phenoconversion (2019) (35)
- Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory (2018) (34)
- Rates of cerebral atrophy in autopsy‐confirmed progressive supranuclear palsy (2006) (34)
- Neuroimaging-evident lesional pathology associated with REM sleep behavior disorder. (2015) (34)
- β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies (2020) (34)
- Clinical features of pathologic subtypes of behavioral--variant frontotemporal dementia. (2007) (33)
- Successful aging: definitions and prediction of longevity and conversion to mild cognitive impairment. (2011) (33)
- Caloric intake, aging, and mild cognitive impairment: a population-based study. (2013) (33)
- White matter integrity in dementia with Lewy bodies: a voxel-based analysis of diffusion tensor imaging (2015) (33)
- Corticospinal tract degeneration associated with TDP-43 type C pathology and semantic dementia. (2013) (33)
- Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology. (2019) (32)
- MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies (2016) (32)
- Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2 (2013) (32)
- Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS (2020) (31)
- Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies (2015) (31)
- Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder (2018) (31)
- Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration (2019) (31)
- Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia (2013) (31)
- Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution (2020) (31)
- Corticobasal Degeneration The Syndrome and the Disease (2004) (30)
- Absence of rapid eye movement sleep behavior disorder in 11 members of the pallidopontonigral degeneration kindred. (2006) (30)
- A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers (2018) (30)
- A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers (2018) (30)
- The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology (2019) (30)
- Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions (2009) (30)
- Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration. (2019) (30)
- Efficacy, Safety, and Tolerability of Armodafinil Therapy for Hypersomnia Associated with Dementia with Lewy Bodies: A Pilot Study (2017) (30)
- Undetectable CSF hypocretin-1 in “Hashimoto’s encephalopathy” associated with coma (2004) (29)
- LRRK2 variation and dementia with Lewy bodies. (2016) (29)
- 18F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus (2018) (29)
- Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy. (2020) (29)
- Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2017) (29)
- Utility of the drs for predicting problems in day-to-day functioning (2010) (28)
- A robust biomarker of large-scale network failure in Alzheimer's disease (2017) (28)
- Validation of consensus panel diagnosis in dementia. (2010) (28)
- Very early semantic dementia with progressive temporal lobe atrophy: an 8-year longitudinal study. (2008) (28)
- Autoimmune Encephalopathies (2007) (28)
- Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer's disease. (2015) (28)
- Improving clinical cognitive testing (2015) (27)
- Lewy Body Dementias. (2017) (27)
- Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers (2019) (27)
- Incidence of dementia among participants and nonparticipants in a longitudinal study of cognitive aging. (2014) (27)
- Comparison of the Short Test of Mental Status and the Montreal Cognitive Assessment Across the Cognitive Spectrum. (2019) (27)
- The influence of apolipoprotein E genotype on visuospatial attention dissipates after age 80. (2009) (27)
- Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration (2021) (26)
- Mild Cognitive Impairment and Risk of Critical Illness* (2016) (26)
- Update on the Diagnosis and Management of Sleep Disturbances in Dementia. (2008) (26)
- Joint associations of β-amyloidosis and cortical thickness with cognition (2018) (26)
- APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia (2021) (26)
- REM sleep behavior disorder (2006) (26)
- Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET (2018) (26)
- Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
- Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies (2020) (25)
- Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration (2020) (25)
- Longitudinal structural and metabolic changes in frontotemporal dementia (2020) (25)
- Parkinson-related dementias. (2007) (25)
- Heritability and genetic variance of dementia with Lewy bodies (2018) (25)
- Clinical characterization of a kindred with a novel 12-octapeptide repeat insertion in the prion protein gene. (2011) (25)
- Antemortem amyloid imaging and β -amyloid pathology in a case with dementia with Lewy Bodies (2012) (25)
- Neuropsychological findings in clinically atypical autopsy confirmed corticobasal degeneration and progressive supranuclear palsy. (2008) (25)
- Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration (2019) (25)
- Long-Term Exercise Training for an Individual With Mixed Corticobasal Degeneration and Progressive Supranuclear Palsy Features: 10-Year Case Report Follow-up (2013) (24)
- Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia (2016) (24)
- Time-to-event voxel-based techniques to assess regional atrophy associated with MCI risk of progression to AD (2011) (24)
- Network-driven plasma proteomics expose molecular changes in the Alzheimer’s brain (2016) (24)
- REM Sleep Behavior Disorder in Parkinson’s Disease, Dementia with Lewy Bodies, and Multiple System Atrophy (2003) (24)
- Tau-negative amnestic dementia masquerading as Alzheimer disease dementia (2018) (24)
- MAPT haplotype diversity in multiple system atrophy. (2016) (23)
- Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutations (1999) (23)
- Cognitive and Noncognitive Neurological Features of Young-Onset Dementia (2009) (23)
- Age and apoE associations with complex pathologic features in Alzheimer's disease (2008) (23)
- Thalamo-cortical network hyperconnectivity in preclinical progranulin mutation carriers (2019) (23)
- Dysarthria and apraxia of speech associated with FK-506 (tacrolimus). (1996) (23)
- Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum (2016) (23)
- GBA variants in REM sleep behavior disorder: a multicenter study (2019) (23)
- Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort (2020) (22)
- Magnetic resonance imaging in the evaluation of knee injuries. (1991) (22)
- MRS in Mild Cognitive Impairment: Early Differentiation of Dementia with Lewy Bodies and Alzheimer's Disease (2015) (22)
- Rapidly Progressive Young-Onset Dementia (2009) (22)
- DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients (2015) (22)
- Amnestic mild cognitive impairment (2017) (22)
- Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations (2022) (22)
- [18F] AV-1451 uptake in corticobasal syndrome: the influence of beta-amyloid and clinical presentation (2018) (21)
- Cognitive and behavioral features of c9FTD/ALS (2012) (21)
- Clinical Features and Survival of 3R and 4R Tauopathies Presenting as Behavioral Variant Frontotemporal Dementia (2007) (21)
- Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials (2020) (21)
- Progressive supranuclear palsy. (2012) (20)
- Elevated medial temporal lobe and pervasive brain tau-PET signal in normal participants (2018) (20)
- RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies (2016) (20)
- Clinical, diagnostic, genetic and management issues in dementia with Lewy bodies. (2005) (20)
- Implicit Learning of Sequential Regularities and Spatial Contexts in Corticobasal Syndrome (2007) (20)
- Autoimmune dementia and encephalopathy. (2016) (20)
- TDP-43 in Alzheimer’s disease is not associated with clinical FTLD or Parkinsonism (2014) (20)
- Characterization of a family with c9FTD/ALS associated with the GGGGCC repeat expansion in C9ORF72. (2012) (19)
- Greatest rapid eye movement sleep atonia loss in men and older age (2014) (19)
- GBA variants in REM sleep behavior disorder (2020) (19)
- Globular Glial Tauopathy Presenting as Semantic Variant Primary Progressive Aphasia. (2016) (19)
- Speech and language disorders associated with corticobasal degeneration (2003) (19)
- 1H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults (2017) (19)
- TREM2 p.R47H substitution is not associated with dementia with Lewy bodies (2016) (19)
- Physical Exercise, Aging, and Mild Cognitive Impairment (2017) (19)
- TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia. (2018) (19)
- An MRI-based strategy for differentiation of frontotemporal dementia and Alzheimer’s disease (2021) (18)
- Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint (2019) (18)
- Rates of lobar atrophy in asymptomatic MAPT mutation carriers (2019) (18)
- Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint (2019) (18)
- Clinicopathologic discrepancies in a population‐based incidence study of parkinsonism in olmsted county: 1991‐2010 (2017) (18)
- The Behavioral Neurology of Dementia: Frontmatter (2009) (18)
- Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases (2021) (18)
- Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment. (2015) (18)
- A kinematic study of progressive apraxia with and without dementia (1999) (18)
- 18F‐AV‐1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy (2019) (18)
- Hypocretin (orexin) and melatonin values in a narcoleptic-like sleep disorder after pinealectomy. (2002) (17)
- Witnessed apneas are associated with elevated tau-PET levels in cognitively unimpaired elderly (2020) (17)
- Evaluating pathogenic dementia variants in posterior cortical atrophy (2016) (17)
- Current and future management of the corticobasal syndrome and corticobasal degeneration. (2008) (17)
- Normative and isolated rapid eye movement sleep without atonia in adults without REM sleep behavior disorder. (2019) (17)
- Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy (2020) (16)
- Patterns of brain atrophy in frontotemporal dementia with mutations in MAPT or PGRN (2009) (16)
- Clinical Phenomenology and Mortality in Charles Bonnet Syndrome (2013) (16)
- A comprehensive screening of copy number variability in dementia with Lewy bodies (2019) (16)
- The GGGGCC Repeat Expansion in C9ORF72 in a Case with Discordant Clinical and FDG-PET Findings: PET Trumps Syndrome (2014) (15)
- Correction: Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families (2012) (15)
- Treatment of Dementia With Lewy Bodies (2013) (15)
- Predicting the future in idiopathic rapid-eye movement sleep behaviour disorder (2010) (15)
- Amnesia after basal forebrain damage due to anterior communicating artery aneurysm rupture (1999) (15)
- Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer’s disease pathology (2005) (15)
- Nonlinear Z-score modeling for improved detection of cognitive abnormality (2019) (14)
- Mutations in protein N-arginine methyltransferases are not the cause of FTLD-FUS (2013) (14)
- Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies (2021) (14)
- FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD (2021) (14)
- Pick’s disease: clinicopathologic characterization of 21 cases (2020) (14)
- Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks (2021) (14)
- MRI correlates of alien leg‐like phenomenon in corticobasal degeneration (2005) (14)
- Autonomic dysfunction and phenoconversion in idiopathic REM sleep behavior disorder (2020) (14)
- A review of the non-Alzheimer dementias. (2006) (13)
- Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies (2017) (13)
- Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers (2019) (13)
- Deep learning-based brain age prediction in normal aging and dementia (2021) (13)
- FTDP‐17 with Pick body‐like inclusions associated with a novel tau mutation, p.E372G (2017) (13)
- MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous (2020) (13)
- Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants (2020) (13)
- The alien limb phenomenon and Creutzfeldt-Jakob disease. (2012) (13)
- Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation (2021) (13)
- Age, family history, and memory and future risk for cognitive impairment (2009) (13)
- Adult-onset autosomal dominant leukodystrophy presenting with REM sleep behavior disorder (2013) (13)
- Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment. (2020) (13)
- Steroid-responsive encephalopathy subsequently associated with Alzheimer's disease pathology: A case series (2012) (13)
- Single-cell profiling of the human primary motor cortex in ALS and FTLD (2021) (13)
- Transient Epileptic Amnesia: A Treatable Cause of Spells Associated With Persistent Cognitive Symptoms (2019) (12)
- Brain volumetric deficits in MAPT mutation carriers: a multisite study (2020) (12)
- LRP10 in α-synucleinopathies (2018) (12)
- Abnormal expression of homeobox genes and transthyretin in C9ORF72 expansion carriers (2017) (12)
- Specialist approaches to prognostic counseling in isolated REM sleep behavior disorder. (2020) (12)
- Predicting Alzheimer's Disease (2009) (12)
- Long-read targeted sequencing uncovers clinicopathological associations for C9orf72-linked diseases (2021) (11)
- Genetic variants associated with susceptibility to psychosis in late-onset Alzheimer’s disease families (2015) (11)
- Effect Modifiers of TDP-43 Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes. (2020) (11)
- Uniform data set language measures for bvFTD and PPA diagnosis and monitoring (2021) (11)
- Is rapid eye movement sleep behavior disorder in Parkinson disease a specific disease subtype? (2013) (11)
- Anatomy of disturbed sleep in pallido‐ponto‐nigral degeneration (2011) (11)
- Trajectory of lobar atrophy in asymptomatic and symptomatic GRN mutation carriers: a longitudinal MRI study (2019) (11)
- Sensitivity of Diagnostic Criteria in Autopsy-Confirmed Patients with Behavioral Variant Frontotemporal Dementia (bvFTD): First Report of the International bvFTD Criteria Consortium (FTDC) (2011) (11)
- Physician and patient determinants of prognostic counseling in idiopathic REM sleep-behavior disorder. (2019) (11)
- REM sleep atonia loss distinguishes synucleinopathy in older adults with cognitive impairment (2019) (11)
- Frontal lobe 1H MR spectroscopy in asymptomatic and symptomatic MAPT mutation carriers (2019) (11)
- Proposed research criteria for prodromal behavioural variant frontotemporal dementia (2022) (11)
- 11 C PiB and Structural MRI Provide Complementary Information in Imaging of AD and Amnestic MCI (2009) (11)
- Clinicopathological and 123I‐FP‐CIT SPECT correlations in patients with dementia (2018) (10)
- Distinctive MRI findings in pallidopontonigral degeneration (PPND) (2007) (10)
- Progranulin: Functions and neurologic correlations (2018) (10)
- Submentalis Rapid Eye Movement Sleep Muscle Activity: A Potential Biomarker for Synucleinopathy (2019) (10)
- Confirmation of 123I-FP-CIT SPECT Quantification Methods in Dementia with Lewy Bodies and Other Neurodegenerative Disorders (2020) (10)
- Revised Self-Monitoring Scale (2020) (10)
- Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia (2019) (10)
- Epidemiology of alpha-synucleinopathies: from Parkinson disease to dementia with Lewy bodies. (2016) (10)
- Alzheimer's Disease Patients' Cognitive Status and Course Years Prior to Symptom Recognition (2007) (10)
- PiB and structural MRI provide complementary information in imaging of Alzheimer ’ s disease and amnestic mild cognitive impairment (2008) (9)
- Association between transactive response DNA-binding protein of 43 kDa type and cognitive resilience to Alzheimer’s disease: a case-control study (2020) (9)
- 18F-fluorodeoxyglucose positron emission tomography in dementia with Lewy bodies (2020) (9)
- Patterns of brain atrophy in frontotemporal dementia with mutations in MAPT or PGRN (2009) (9)
- Association Between Microinfarcts and Blood Pressure Trajectories (2017) (9)
- The temporal onset of the core features in dementia with Lewy bodies (2021) (9)
- The Degenerative Dementias (2007) (9)
- Excessive Daytime Sleepiness in Major Dementia Syndromes (2019) (9)
- Linear vs volume measures of ventricle size (2019) (9)
- CSF1R mutation presenting as dementia with Lewy bodies (2019) (9)
- Incidence of frontotemporal disorders in Olmsted County: A population-based study (2019) (8)
- Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes (2021) (8)
- Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting Proceedings (2019) (8)
- Brain MR Spectroscopy Changes Precede Frontotemporal Lobar Degeneration Phenoconversion in Mapt Mutation Carriers (2019) (8)
- Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia (2021) (8)
- Comprehensive Analysis of Familial Parkinsonism Genes in Rapid‐Eye‐Movement Sleep Behavior Disorder (2020) (8)
- Timeline of Rapid Eye Movement Sleep Behavior Disorder in Overt Alpha‐Synucleinopathies (2020) (8)
- Clinical correlates of RBD in early Parkinson disease (2014) (8)
- Chiari 1 Malformation Presenting as Central Sleep Apnea during Pregnancy: A Case Report, Treatment Considerations, and Review of the Literature (2014) (8)
- 3D Maps from Multiple MRI Illustrate Changing Atrophy Patterns as Subjects Progress from MCI to AD (2009) (8)
- APOE ɛ4 Allele Testing and Risk of Alzheimer Disease. (2021) (8)
- Longitudinal anatomic, functional, and molecular characterization of Pick disease phenotypes (2020) (8)
- Ramelteon for Idiopathic REM Sleep Behavior Disorder: Implications for Pathophysiology and Future Treatment Trials. (2016) (7)
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into the complex genetic architecture (2020) (7)
- The influence of β-amyloid on [18F]AV-1451 in semantic variant of primary progressive aphasia (2019) (7)
- Clinical and electrophysiologic variability in amyotrophic lateral sclerosis within a kindred harboring the C9ORF72 repeat expansion (2013) (7)
- P2-107: Anxiety and apathy are associated with probable REM sleep behavior disorder among cognitively normal elderly subjects: The Mayo Clinic study of aging (2008) (7)
- Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort (2020) (7)
- Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency (2021) (7)
- Novel Associations of BST1 and LAMP3 With REM Sleep Behavior Disorder (2021) (7)
- Alzheimer's Disease and Other Dementias (2011) (7)
- Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium (2021) (7)
- Traumatic brain injury is associated with subsequent neurologic and psychiatric disease: a meta-analysis (2016) (7)
- Shapes of the Trajectories of Five Major Biomarkers of Alzheimer’s Disease (2013) (7)
- HEADWAY-DLB: A MULTINATIONAL STUDY EVALUATING THE SAFETY AND EFFICACY OF INTEPIRDINE (RVT-101) IN DEMENTIA WITH LEWY BODIES (2017) (7)
- Neuroprotection in idiopathic REM sleep behavior disorder: a role for exercise? (2019) (6)
- Practice effects and longitudinal cognitive change in normal aging versus incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging (2013) (6)
- An analysis of global research funding for the frontotemporal dementias: 1998–2008 (2011) (6)
- MRI quantitative susceptibility mapping of the substantia nigra as an early biomarker for Lewy body disease (2021) (6)
- Posterior cortical atrophy phenotypic heterogeneity revealed by decoding 18F-FDG-PET (2021) (6)
- Erratum: REM sleep behavior disorder and REM sleep without atonia as an early manifestation of degenerative neurological disease (Current Neurology and Neuroscience Reports DOI: 10.1007/s11910-012-0253-z) (2012) (6)
- A familial form of parkinsonism, dementia, and motor neuron disease: a longitudinal study. (2014) (6)
- Safety, Tolerability, and Efficacy of Armodafinil Therapy for Hypersomnia Associated with Dementia with Lewy Bodies (P04.192) (2012) (6)
- Quantitative analyses of REM sleep without atonia in children and adolescents with REM sleep behavior disorder. (2014) (6)
- Can Clinical Features Predict Tau Pathology in Patients with Behavioral Variant Frontotemporal Dementia (bvFTD)? (P05.101) (2013) (6)
- Progressive Supranuclear Palsy and Corticobasal Syndrome: A Population-Based Study. (2020) (6)
- Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy (2020) (6)
- Neuropsychological characterization of evolving cognitive decline in idiopathic REM sleep behavior disorder is important, but not easy. (2011) (5)
- Characterization of a Family With c 9 FTD / ALS Associated With the GGGGCC Repeat Expansion in C 9 ORF 72 (2012) (5)
- Phenoconversion from probable rapid eye movement sleep behavior disorder to mild cognitive impairment to dementia in a population-based sample (2017) (5)
- Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders (2022) (5)
- MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features (2020) (5)
- Non-Amnestic Mild Cognitive Impairment Progresses to Dementia with Lewy Bodies (S24.002) (2013) (5)
- TDP-43 is associated with a reduced likelihood of rendering a clinical diagnosis of dementia with Lewy bodies in autopsy-confirmed cases of transitional/diffuse Lewy body disease (2020) (5)
- Pittsburgh compound B (PiB) PET imaging of meningioma and other intracranial tumors (2017) (5)
- Characterization of frontotemporal dementia +/- amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 (2012) (5)
- The value of multimodal imaging with 123I-FP-CIT SPECT in differential diagnosis of dementia with Lewy bodies and Alzheimer's disease dementia (2020) (5)
- SLEEP AND NEURODEGENERATIVE DISORDERS (2007) (5)
- Age related changes in the default mode network are more advanced in Alzheimer's disease (2011) (5)
- Evidence for cholinesterase-inhibitor therapy for dementia associated with Parkinson's disease (2005) (5)
- 2-30-01 Clinicopathologic heterogeneity in clinically- and/or pathologically-diagnosed cortical-basal ganglionic degeneration (1997) (4)
- Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects (2022) (4)
- Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design (2022) (4)
- Outcome Measures for Dementia With Lewy Body Clinical Trials (2021) (4)
- Current Issues in Lewy Body Dementia Diagnosis, Treatment and Research (2012) (4)
- Neurodegenerative Disorders (2010) (4)
- Uptake of AV-1451 in meningiomas (2017) (4)
- HYPERMANGANESEMIA, HEREDITARY HEMORRHAGIC TELANGIECTASIA, BRAIN ABSCESS: THE HEPATIC CONNECTION (2008) (4)
- The Behavioral Neurology of Dementia: Early clinical features of the parkinsonian-related dementias (2009) (4)
- P4-136: Parkinsonism is associated with probable REM sleep behavior disorder in cognitively normal elderly subjects: The Mayo Clinic Study of Aging (2008) (4)
- Chapter 103 – Rapid Eye Movement Sleep Parasomnias (2017) (4)
- REGIONAL DIFFUSIVITY OF WATER IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE (2009) (4)
- Temporal order of clinical and biomarker changes in familial frontotemporal dementia (2022) (4)
- TAR DNA-Binding Protein 43 Is Associated with Rate of Memory, Functional and Global Cognitive Decline in the Decade Prior to Death (2021) (4)
- Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90 (2022) (4)
- Neuromelanin-sensitive imaging in patients with idiopathic rapid eye movement sleep behaviour disorder. (2016) (4)
- Genome-wide association study of REM sleep behavior disorder identifies novel loci with distinct polygenic and brain expression effects (2021) (4)
- A comprehensive analysis of dominant and recessive parkinsonism genes in REM sleep behavior disorder (2020) (4)
- Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies (2022) (4)
- Diffusion tensor imaging characteristics of amnestic and non-amnestic mild cognitive impairment (2009) (4)
- β-Amyloid PET and 123I-FP-CIT SPECT in Mild Cognitive Impairment at Risk for Lewy Body Dementia (2021) (4)
- P2-108: Lower scores in attention/executive functioning are associated with probable REM sleep behavior disorder among cognitively normal elderly subjects: The Mayo Clinic study of aging (2008) (4)
- Sleep disorders in neurodegenerative diseases other than Parkinson's disease. (2011) (4)
- Patterns of neurodegeneration in dementia reflect a global functional state space (2020) (4)
- Measurement of grey matter water diffusion in the clinical variants of frontotemporal lobar degeneration and Alzheimer's disease (2009) (4)
- Progress on progranulin. (2010) (4)
- Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal (2021) (4)
- Patient Values and Preferences Regarding Prognostic Counseling in Isolated REM Sleep Behavior Disorder. (2022) (4)
- TRAJECTORY OF LOBAR ATROPHY IN ASYMPTOMATIC AND SYMPTOMATIC GRN MUTATION CARRIERS: A LONGITUDINAL TBM-SYN STUDY (2019) (3)
- Amyloid- b deposition and regional grey matter atrophy rates in dementia with Lewy bodies (2016) (3)
- TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease (2013) (3)
- An 81-year-old man with imbalance and memory impairment (2007) (3)
- Electrocardiographic and echocardiographic changes associated with malignant catatonia. (1994) (3)
- LONGITUDINAL CHANGES IN BRAIN MRI AND NEUROPSYCHOLOGICAL MEASURES IN ASYMPTOMATIC AND SYMPTOMATIC FAMILIAL FRONTOTEMPORAL LOBAR DEGENERATION WITH MUTATIONS IN MAPT (2014) (3)
- Magnetic resonance elastography of frontotemporal dementia: MRE of Frontotemporal Dementia (2016) (3)
- Multimodal imaging in familial FTLD: phenoconversion and planning for the future. (2019) (3)
- Case Report: Early-Onset Behavioral Variant Frontotemporal Dementia in Patient With Retrotransposed Full-Length Transcript of Matrin-3 Variant 5 (2020) (3)
- Phenotypic subtypes of progressive dysexecutive syndrome due to Alzheimer’s disease: a series of clinical cases (2022) (3)
- REM Sleep Behavior Disorder Associated with Dementia with Lewy Bodies (2019) (3)
- Sleep in Parkinson’s Disease and Dementia with Lewy Bodies (2012) (3)
- Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group (2021) (3)
- Slow gait predicts cognitive decline: A population-based cohort study (2012) (3)
- SMPD1 variants do not have a major role in rapid eye movement sleep behavior disorder (2020) (3)
- Amyloid- and tau-PET imaging in a familial prion kindred (2018) (3)
- The behavioral neurology of dementia: Second edition (2016) (3)
- Frequency and distribution of TAR DNA-binding protein 43 (TDP-43) pathology increase linearly with age in a large cohort of older adults with and without dementia (2022) (3)
- Differential effect of dementia etiology on cortical stiffness as assessed by MR elastography (2023) (3)
- Cerebral Amyloid Angiopathy Burden and Cerebral Microbleeds: Pathological Evidence for Distinct Phenotypes. (2021) (3)
- The contribution of behavioral features to caregiver burden in FTLD spectrum disorders (2021) (3)
- Objective Sleep Profile in LGI1/CASPR2 Autoimmunity. (2021) (3)
- Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations (2021) (3)
- TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration (2022) (3)
- A 75-year-old man with cognitive impairment and gait changes (2007) (3)
- Levodopa-induced dyskinesia in dementia with Lewy bodies and Parkinson disease with dementia. (2020) (3)
- Anteromedial temporal lobe diffusion tensor imaging and structural MRI changes in presymptomatic and symptomatic microtubule-associated protein tau (MAPT) mutation carriers (2012) (3)
- Chapter 71 – Alzheimer's Disease and Other Dementias (2005) (3)
- Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis (2020) (3)
- P1-288: Automated ROI analysis of 11C Pittsburgh compound B images using structural magnetic resonance imaging atlases (2008) (3)
- SYMPTOM ONSET IN GENETIC FRONTOTEMPORAL DEMENTIA (2017) (3)
- Genetic risk factors for posterior cortical atrophy (2015) (3)
- Letter on “Natural history of pure autonomic failure: A United States prospective cohort” (2017) (2)
- Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: A population-based study (2011) (2)
- Protocol for an observational cohort study identifying factors predicting accurately end of life in dementia with Lewy bodies and promoting quality end-of-life experiences: the PACE-DLB study (2021) (2)
- Tau Mutations as a Novel Risk Factor for Cancer-Letter. (2018) (2)
- Diagnostic REM Sleep Muscle Activity Thresholds in Idiopathic REM Sleep Behavior Disorder Patients with and without Obstructive Sleep Apnea (2017) (2)
- NONLINEAR N-SCORE ESTIMATION FOR ESTABLISHING COGNITIVE NORMS FROM THE NATIONAL ALZHEIMER’S COORDINATING CENTER (NACC) DATASET (2018) (2)
- MRS in Early and Presymptomatic Carriers of a Novel Octapeptide Repeat Insertion in the Prion Protein Gene (2013) (2)
- Corrigendum to “Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group” [Sleep Med 14(8) (2013) 795–806] (2014) (2)
- Poly (ADP-Ribose) and α–synuclein extracellular vesicles in patients with Parkinson disease: A possible biomarker of disease severity (2022) (2)
- Cytokine and Leukocyte Profiling Reveal Pro-Inflammatory and Autoimmune Features in Frontotemporal Dementia Patients (2016) (2)
- Abnormal REM Sleep Atonia Control in Chronic Post-Traumatic Stress Disorder. (2021) (2)
- Age-Specific Incidence Rate For Dementia And Alzheimer’s Disease In NIA-LOAD/NCRAD and EFIGA Families (P2.148) (2014) (2)
- Multimodal imaging in familial FTLD: phenoconversion and planning for the future. (2019) (2)
- Limb immobilization and corticobasal syndrome. (2012) (2)
- Nonstationarity in the modular architecture of the “resting brain” (2012) (2)
- Clinicopathologic Correlations in 172 Cases of REM Sleep Behavior Disorder ± a Coexisting Neurologic Disorder (PL01.003) (2013) (2)
- Antemortem hippocampal atrophy predicts presence of Alzheimer's disease pathology in pathologically proven lewy body disease (2011) (2)
- Examination of default mode network activity along the cognitive continuum: Normal aging, MCI and Alzheimer's disease (2009) (2)
- Evidence of cerebellar TDP-43 loss of function in FTLD-TDP (2022) (2)
- Sleep, Cognitive Dysfunction, and Dementia (2015) (2)
- Lifelong constipation in Parkinson's disease and other clinically defined alpha-synucleinopathies: A population-based study in Southeast Minnesota. (2022) (2)
- Extensive S aureus spinal epidural empyema. (2005) (2)
- PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE HISTONE DEACETYLASE INHIBITOR (HDACI), FRM-0334, IN ASYMPTOMATIC CARRIERS OF, OR PATIENTS WITH FRONTOTEMPORAL LOBAR DEGENERATION (FTLD) DUE TO, PROGRANULIN GENE MUTATIONS (2019) (2)
- AMYLOID-B, NEUROPSYCHIATRIC SYMPTOMS AND THE RISK OF INCIDENT MILD COGNITIVE IMPAIRMENT: THE MAYO CLINIC STUDY OF AGING (2016) (2)
- Rapid eye movement sleep behavior disorder : devising controlled active treatment studies for symptomatic and neuroprotective therapy — a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder (2013) (2)
- Risk Factors for Dementia with Lewy Bodies (S24.005) (2012) (2)
- NETWORK-BASED TAU DEPOSITION PATTERNS ARE RELATED TO FUNCTIONAL NETWORK FAILURE LARGELY VIA BETA-AMYLOID ACROSS THE ALZHEIMER’S SPECTRUM (2016) (2)
- The North American Prodromal Synucleinopathy (NAPS) Consortium: Baseline neuropsychological findings in 136 participants (2020) (2)
- Progranulin (2018) (2)
- Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2018) (2)
- O2-01-01: The Mayo Clinic study of aging: Incidence of mild cognitive impairment (2008) (2)
- Rare PSAP Variants and Possible Interaction with GBA in REM Sleep Behavior Disorder. (2021) (2)
- The Neuropathology of Patients with Dementia and Non-Dementia in the Oldest-old (P2.176) (2015) (2)
- P3-343 Progressive supranuclear palsy presenting as progressive nonfluent aphasia (2004) (2)
- P3-068 Myo-inositol/creatine ratio correlates with the neuropathological involvement in Alzheimer's disease (2004) (2)
- Differential diagnosis of neurodegenerative dementias using structural MRI (2009) (2)
- Mild cognitive impairment in rapid eye movement sleep behavior disorder: a predictor of dementia? (2013) (2)
- GRN Mutations Are Associated with Lewy Body Dementia (2022) (2)
- ApoE and quality of life in nonagenarians. (2012) (2)
- Clinical and Neuroimaging Aspects of Familial Frontotemporal Lobar Degeneration Associated with MAPT and GRN Mutations. (2021) (2)
- Erratum to: Network-driven plasma proteomics expose molecular changes in the Alzheimer’s brain (2016) (2)
- Quantitative measurement of cerebral hypoperfusion and atrophy in Alzheimer's disease using MRI (2009) (2)
- Fine-mapping of SNCA in REM sleep behavior disorder and overt synucleinopathies (2019) (2)
- NETWORK-BASED TAU DEPOSITION PATTERNS ARE RELATED TO FUNCTIONAL NETWORK FAILURE LARGELY VIA BETA-AMYLOID ACROSS THE ALZHEIMER’S SPECTRUM (2016) (2)
- Rare PSAP variants and possible interaction with GBA in REM sleep behavior disorder (2021) (2)
- VENTRICULOMEGALY IS A BIOMARKER OF GAIT AND COGNITIVE DECLINE (2017) (2)
- Electroencephalogram findings in patients with posterior cortical atrophy. (2018) (1)
- Longitudinal clinical, neuropsychological, and neuroimaging characterization of a kindred with a 12-octapeptide repeat insertion in PRNP: the next generation (2020) (1)
- P2-193 Progression of cognitive impairments in mild cognitive impairment: What is the next domain to be impaired after memory? (2006) (1)
- Non-amnestic mild cognitive impairment (2017) (1)
- TDP-43 pathology effect on volume and flortaucipir uptake in Alzheimer's disease. (2022) (1)
- 0273 BASELINE EXCESSIVE DAYTIME SLEEPINESS ASSOCIATED WITH AN INCREASE IN BRAIN METABOLISM IN NON-DEMENTED ELDERLY: A LONGITUDINAL FDG-PET STUDY (2017) (1)
- Immune-related genetic enrichment in frontotemporal dementia (2017) (1)
- WHOLE EXOME SEQUENCING ANALYSIS IN EARLY ONSET ALZHEIMER REVEALS NOVEL CANDIDATE GENES (2019) (1)
- Frontal-Subcortical Circuits in Psychiatricand Neurological Disorders (2002) (1)
- Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degeneration (2022) (1)
- Kluver-Bucy syndrome in traumatic brain injury: A case study (1997) (1)
- REM Sleep Behavior Disorder and REM‐Related Parasomnias (2005) (1)
- Comprar The Behavioral Neurology Of Dementia 2nd Ed. | Bruce L. Miller | 9781107077201 | Cambridge University Press (2016) (1)
- Sleepiness in Cognitively Unimpaired Older Adults Is Associated With CSF Biomarkers of Inflammation and Axonal Integrity (2022) (1)
- Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old (2022) (1)
- Nomenclature of “Paroxysmal Sympathetic Storms”: In Response (1999) (1)
- Progressive dysexecutive syndrome due to Alzheimer’s disease: A description of 55 cases and comparisons to other clinical AD phenotypes (2020) (1)
- TDP-43 AMPLIFIES MEMORY LOSS AND HIPPOCAMPAL ATROPHY IN ALZHEIMER'S DISEASE (2014) (1)
- 0725 TIME COURSE FOR PHENOCONVERSION TO A DEFINED NEURODEGENERATIVE DISEASE IN WOMEN WITH IDIOPATHIC REM SLEEP BEHAVIOR DISORDER WITH AND WITHOUT ANTIDEPRESSANT USE (2017) (1)
- Imaging prodromal FTD (2013) (1)
- Excessive daytime sleepiness is comparable in behavioral variant frontotemporal dementia and Alzheimer's disease dementia but greater in dementia with lewy bodies (2015) (1)
- Does Progression and Mortality in Mild Cognitive Impairment Vary in Men and Women? The Mayo Clinic Study of Aging (P07.155) (2012) (1)
- Outcomes of MCI: The Mayo Clinic study of aging (2011) (1)
- Frontal asymmetry in behavioral variant FTD: clinicoimaging & pathogenetic correlates (2012) (1)
- The Behavioral Neurology of Dementia: Dementia treatment (2009) (1)
- What more can we learn from studying the REM sleep behaviour disorder–Parkinson’s disease association? (2008) (1)
- 1154 THE EFFECTS OF CPAP ON COGNITIVE AND FUNCTIONAL MEASURES IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DEMENTIA (2017) (1)
- Characteristics and Progress on 312 Subjects in the Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS) Protocol (P3.036) (2018) (1)
- Subject Index Vol. 14, 2002 (2002) (1)
- SMPD1 variants do not have a major role in REM sleep behavior disorder (2020) (1)
- Risk of Dementia in Persons Who Refused To Participate in a Longitudinal Study of Cognitive Aging (P01.083) (2012) (1)
- P2-221: Daytime hypersomnolence on the multiple sleep latency test in patients with dementia with Lewy bodies (2008) (1)
- Multimodal imaging in familial FTLD: phenoconversion and planning for the future. (2019) (1)
- P01-370 - Impact on Caregivers from Sleep Disturbances is Higher in Dementia with Lewy Bodies as Compared to Alzheimer's Dementia (2010) (1)
- Focal Cortical Patterns in Hippocampal Sparing AD Reveal Significant Clinical Differences (S48.001) (2014) (1)
- The Prevalence and Prognosis of Patients with Enlarged Ventricles (P4.034) (2016) (1)
- Novel GRN mutation presenting as an aphasic dementia and evolving into corticobasal syndrome (2017) (1)
- Non-REM sleep with hypertonia in Parkinsonian Spectrum Disorders: A pilot investigation (2022) (1)
- Synthesizing Images of Tau Pathology from Cross-modal Neuroimaging using Deep Learning (2022) (1)
- Detection of emerging neurodegeneration using Bayesian linear mixed-effect modeling (2022) (1)
- Incidence of Dementia with Lewy Bodies and Parkinsonism with Dementia (P03.097) (2013) (1)
- Clinical and Survival Profiles of Patients with Frontotemporal Dementia and Motor Neuron Disease (2009) (1)
- NEUROPATHOLOGIC FEATURES OF AV1451 TAU PET AUTORADIOGRAPHY IN DEMENTIA (2016) (1)
- A kindred with familial frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 (2012) (1)
- Diagnostic Thresholds for Quantitative REM Sleep Muscle Densities, Phasic Burst Duration, and REM Atonia Index in REM Sleep Behavior Disorder with Co-morbid Obstructive Sleep Apnea (P5.283) (2013) (1)
- Dementia with Lewy Bodies: Pathological Basis of the Cingulate Island Sign (P6.332) (2014) (1)
- P2-219: Polysomnographic evidence of sleep fragmentation and poor sleep efficiency in dementia with Lewy bodies (2008) (1)
- Mayo's Older Americans Normative Studies: Visual Form Discrimination and copy trial of the Rey-Osterrieth Complex Figure (Journal of Clinical and Experimental Neuropsychology (2007) 29, 4, (377-384)) (2008) (1)
- CHARACTERISTICS AND PROGRESS ON THE INITIAL 209 SUBJECTS IN THE LONGITUDINAL EVALUATION OF FAMILIAL FRONTOTEMPORAL DEMENTIA SUBJECTS (LEFFTDS) PROTOCOL (2017) (1)
- LONGITUDINAL MRI AND NEUROPSYCHOLOGICAL CHANGES IN SYMPTOMATIC FRONTOTEMPORAL LOBAR DEGENERATION SUBJECTS WITH MUTATIONS IN MAPT, PGRN, AND C9ORF72 (2014) (1)
- Persistent cauda equina syndrome following bilateral aortoiliac dissection as a complication of cardiac angiography. (1997) (1)
- Advancing research and treatment of frontotemporal lobar degeneration (ARTFL): Preparing for clinical trials for ftld in north america (2015) (1)
- Lipid metabolism dysfunction in progranulin mutation carriers: Unbiased metabolomics reveals strong relationship to clinical status in FTLD (2020) (1)
- IMPAIRED SEGREGATION OF THE VENTRAL DEFAULT MODE NETWORK IN ALZHEIMER'S DISEASE (2014) (1)
- MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies (2023) (1)
- Neuropsychiatric Symptoms, ApoE4 and the Risk Of Incident Dementia: The Mayo Clinic Study of Aging (P3.215) (2014) (1)
- Dual pathologies: Utility of TAR DNA‐binding Protein 43 (TDP‐43) Staining in Patients with Frontal and Temporal Lobe Abnormalities and Alzheimer disease (2007) (1)
- Neuroanatomical Signature of C9ORF72: A Comparison to MAPT, Progranulin and Sporadic FTD (P05.061) (2012) (1)
- Pattern Of Brain Atrophy Rates On Serial MRI In Autopsy-Confirmed Dementia With Lewy Bodies (S48.004) (2014) (1)
- In dementia with Lewy bodies, rapid eye movement sleep behavior disorder is associated with reduced Alzheimer's disease pathology and hippocampal atrophy (2012) (1)
- The relationship of primary age-related tauopathy (PART) to snap: Controversy or parallel? (2015) (1)
- Examination of default mode network activity along the cognitive continuum: Normal aging, MCI and AD (2009) (1)
- Transthyretin as Potential Biomarker for C9ORF72-related Diseases (I8-2A) (2015) (1)
- Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meeting (2021) (1)
- Caloric Intake, Aging, and Mild Cognitive Impairment: A Population-Based Study (P04.211) (2012) (1)
- Positron Emission Tomography-Computed Tomography in Paraneoplastic Neurologic Disorders (2017) (1)
- The Alien Limb Phenomenon & Creutzfeldt-Jakob Disease (P03.257) (2012) (1)
- Multimodal imaging in RBD — present and future (2018) (1)
- Regional Brain Stiffness Analysis of Dementia with Lewy Bodies (2021) (1)
- Incidence, Prevalence, and Mortality of Psychosis Associated with Parkinson Disease (1991-2010). (2022) (1)
- Multimodality imaging differentiates dementia with lewy bodies from Alzheimer's disease (2011) (1)
- Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds. (2022) (1)
- P4-118 MRI correlates of the language and behavioral variants of frontotemporal dementia when both are characterized by ubiquitin-only immunoreactive changes (2006) (1)
- Chapter 96 – Alzheimer Disease and Other Dementias (2017) (1)
- MRS differentiates MCI patients who progress to dementia with Lewy bodies and Alzheimer's disease (2013) (1)
- Deciphering the clinico‐radiological heterogeneity of dysexecutive Alzheimer’s disease using unsupervised machine learning techniques (2022) (1)
- 527 Patient-Reported Treatment Outcomes in the Mayo Clinic REM Sleep Behavior Disorder Registry: Efficacy of Melatonin and Clonazepam (2021) (1)
- Identification of noninvasive screening variables for the prediction of amyloid accumulation in a population-based study of cognitively normal elderly individuals (2012) (1)
- NPC1 variants are not associated with Parkinson’s disease, REM-sleep behavior disorder or dementia with Lewy bodies in European cohorts (2020) (1)
- Globular Glial Tauopathy Presenting as Semantic Variant PPA (P6.226) (2016) (1)
- Sleep issues in dementia (2016) (1)
- IC-P1-037: Functional magnetic resonance imaging activation patterns in cognitively normal elderly, amnestic, and non-amnestic Mild Cognitive Impairment during a recognition memory task (2008) (1)
- 0660 Higher Amounts of REM Sleep without Atonia Predict Phenoconversion To Defined Neurodegenerative Disorders in Idiopathic REM Sleep Behavior Disorder (2018) (1)
- Survival and Risk of Mortality of Clinically-Diagnosed Synucleinopathies: A 15 Year Population-Based Study (1991 - 2005) (P3.350) (2016) (1)
- Identification of non-invasive screening variables for the prediction of amyloid accumulation in a population-based study of cognitively normal elderly individuals (2012) (1)
- 0003 LGI1 and CASPR2 Autoimmunity: Sleep Symptoms, Polysomnography, and Quantitative REM Sleep without Atonia (2020) (1)
- NIA-AA MCI criteria applied to the Mayo Clinic Study of Aging (2012) (1)
- Determinants of survival in autopsy-confirmed patients with behavioral variant frontotemporal dementia (bvFTD): Second Report of the international bvFTD criteria consortium (FTDC) (2011) (1)
- Parkinsonism and Related Dementias (2021) (0)
- Association of cortical and subcortical microstructure with disease severity: impact on cognitive decline and language impairments in frontotemporal lobar degeneration (2023) (0)
- Investigating the genetic architecture of Dementia with Lewy bodies: a genome-wide association study (2018) (0)
- Demographic and Etiologic Characteristics of 235 Patients (2016) (0)
- OP-BRAI180237 2895..2907 (2018) (0)
- REM Sleep Behavior Disorder Measure (2015) (0)
- CAREGIVER BURDEN IN FAMILIAL FRONTOTEMPORAL DEMENTIA SUBJECTS: PRELIMINARY DATA IN THE LEFFTDS COHORT (2017) (0)
- Rates of PIB accumulation do plateau (2012) (0)
- Regional patterns of 11C-PiB uptake and cortical atrophy distinguishes dementia with Lewy bodies from Alzheimer's disease (2010) (0)
- Aberrant tau and amyloid pathology underlies 1H MR spectroscopic alterations in Alzheimer's disease and Lewy body disease (2013) (0)
- IC-P2-108: MRI and 1H MRS markers are complementary in predicting risk of future dementia in mild cognitive impairment (2008) (0)
- In dementia with Lewy bodies RBD is associated with reduced Alzheimer's disease pathology and hippocampal atrophy (2012) (0)
- Quantitative Analysis of REM Sleep Without Atonia in Neurocognitive Syndromes (S53.004) (2015) (0)
- Technology‐assisted caregiver matching to address isolation and stress (2021) (0)
- Systems fail before molecules spread: A cascading failure model of Alzheimer’s disease (2015) (0)
- Sex differences in brain atrophy in dementia with Lewy bodies (2023) (0)
- APATHY AND REDUCED STRIATAL UPTAKE IN DEMENTIA WITH LEWY BODIES (2014) (0)
- Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal Dementia (2022) (0)
- Preliminary diagnostic criteria for prodromal behavioral variant frontotemporal dementia: Mild behavioral and/or cognitive impairment (2021) (0)
- Multimodal imaging in familial FTLD: phenoconversion and planning for the future. (2019) (0)
- O1-01-07: Frequency and clinical correlates of parkinsonism in the community-dwelling elderly: The Mayo Clinic study of aging (2008) (0)
- Synthesizing Images of Tau Pathology from Images of Glucose Utilization (2022) (0)
- Normative EMG values and isolated rapid eye movement sleep without atonia frequency in adults without REM sleep behavior disorder (2019) (0)
- Plasma neurofilament light chain levels reflect caregiver burden and social cognition measures in familial frontotemporal lobar degeneration (FTLD) (2020) (0)
- Construct Validity of the ALLFTD Mobile App Cognitive Tests: Associations with Gold Standard Clinical Measures and Brain Volume (2022) (0)
- Predictors of injury in REM sleep behavior disorder (2013) (0)
- MR SPECTROSCOPY FROM FRONTAL LOBE AND POSTERIOR CINGULATE GYRUS IN ASYMPTOMATIC AND SYMPTOMATIC MICROTUBULE-ASSOCIATED PROTEIN TAU (MAPT) MUTATION CARRIERS (2018) (0)
- A STUDY TO MODEL RATES OF CHANGE ON NEUROPSYCHOLOGICAL TEST MEASURES IN SUBJECTS DIAGNOSED WITH BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA AND HEALTHY SUBJECTS (2017) (0)
- Erratum: When do α-synucleinopathies start? An epidemiological timeline: A review (JAMA Neurology (2018) 75:4 (503-509) DOI: 10.1001/jamaneurol.2017.4243) (2018) (0)
- Clinical Dementia Rating Score 0.5 Predicts Clinical Decline in Familial Frontotemporal Dementia (S48.007) (2018) (0)
- Plasma biomarkers of inflammation reflect disease state in autosomal dominant forms of familial frontotemporal dementia (2020) (0)
- Brief smell identification test performance in RBD, DLB and AD (2021) (0)
- GRAY MATTER DEFICITS IN SYMPTOMATIC AND PRESYMPTOMATIC MAPT MUTATION CARRIERS (2018) (0)
- 0722 NEURODEGENERATIVE BIOMARKER FREQUENCY IN IDIOPATHIC REM SLEEP BEHAVIOR DISORDER (2017) (0)
- Alzheimer disease Short-term clinical outcomes for stages of NIAAA preclinical (2012) (0)
- 0267 The Influence of Antidepressants on Non-REM Hypertonia (2022) (0)
- Diabetes Is Associated with Global and Regional Hypometabolism among Elderly Persons: The Mayo Clinic Study of Aging (P07.137) (2013) (0)
- Witnessed Apneas During Sleep are Associated with Elevated Tau-PET Signal in the Entorhinal Cortex in Cognitively Unimpaired Elderly (P3.6-021) (2019) (0)
- NEUROPSYCHOLOGICAL AND MRI FINDINGS IN MAPT MUTATION CARRIERS IN THE EVOLUTION FROM THE ASYMPTOMATIC TO SYMPTOMATIC STATE (2016) (0)
- Amyloid PET in the Lewy Body disease continuum (2022) (0)
- Jakob–Creutzfeldt disease and other prion diseases (2017) (0)
- PRINCIPAL AXES OF PHENOTYPIC VARIABILITY IN ALZHEIMER’S DISEASE DERIVED FROM AN FDG-PET BASED, UNSUPERVISED MACHINE LEARNING ALGORITHM (2018) (0)
- P1-279: The plasma level of c-reactive protein is associated with prevalent mild cognitive impairment (2008) (0)
- PHENOCONVERSION FROM ASYMPTOMATIC TO MINIMALLY SYMPTOMATIC FTLD: PRELIMINARY DATA IN THE LEFFTDS COHORT (2017) (0)
- Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease (2018) (0)
- Age-specific incidence rates of Alzheimer's disease in family members participating in the NIA-LOAD genetics study (2013) (0)
- AD-Related Pathology and Gray Matter Atrophy Rates in Probable Dementia with Lewy Bodies (P6.232) (2016) (0)
- A global functional network biomarker across aging and dysexecutive Alzheimer’s disease (2022) (0)
- Atypical Parkinsonian Syndromes (2015) (0)
- Clinician‐reported features in MBI/MCI and early dementia in genetic FTLD (2020) (0)
- PET TAU IMAGING WITH AV-1451 IN MICROTUBULE ASSOCIATED PROTEIN TAU (MAPT) MUTATION CARRIERS RELATIVE TO ALZHEIMER’S DISEASE DEMENTIA AND CONTROLS (2016) (0)
- P4-120 Demystifying the degenerative aphasias and apraxia of speech (2006) (0)
- Multimodal imaging in familial FTLD: phenoconversion and planning for the future. (2019) (0)
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration (2020) (0)
- FDG-PET and PiB-PET imaging in asymptomatic at-risk carriers of a novel octapeptide repeat insertion in PRNP (2013) (0)
- IC-P-063 ATOPOGRAPHIC IMAGING BIOMARKER OF TDP43 PATHOLOGY IN AMNESTIC DEMENTIA BASED ON AUTOPSY- DERIVED FDG-PET PATTERNS (2019) (0)
- Effects of Aβ load on task-free fMRI abnormalities in dementia with Lewy bodies (2012) (0)
- Latent space projection of brain FDG‐PET creates a powerful classifier for neurodegenerative diseases (2022) (0)
- Thursday, March 15, 2007. pp. 9–58 (2007) (0)
- Cognitive disorders of the very old (2017) (0)
- 0787 Autonomic Dysfunction and Phenoconversion in Idiopathic/Isolated REM Sleep Behavior Disorder (2020) (0)
- Evolution of the core clinical features of dementia with Lewy bodies (2020) (0)
- Studying the natural history of frontotemporal lobar degeneration (FTLD): The ARTFL LEFFTDS longitudinal FTLD (ALLFTD) protocol (2020) (0)
- Infarctions on antemortem MRI are associated with the presence of microinfarcts at autopsy (2012) (0)
- CORTICAL MICROINFARCTS AND REGIONAL GRAY MATTER LOSS ON ANTEMORTEM MRI (2016) (0)
- Predicting survival in dementia with lewy bodies: The importance of hippocampal volume (2015) (0)
- FAMILIAL PICKʼS DISEASE-DOES IT REALLY EXIST? (1999) (0)
- IC-P2-135: Tensor based morphometry test retest validation in AD subjects (2008) (0)
- DIAGNOSTIC UTILITY OF [18F]AV-1451 PET, FDG-PET AND MRI TO DIFFERENTIATE THE THREE VARIANTS OF PRIMARY PROGRESSIVE APHASIA (2018) (0)
- PATTERN OF HYPOPERFUSION ON ASL OVERLAPS WITH HYPOMETABOLISM ON FDG-PET IN DEMENTIA WITH LEWY BODIES (2017) (0)
- Predictors of Neurodegeneration in Idiopathic REM sleep behavior disorder: a multicenter cohort study (CCI.003) (2018) (0)
- MULTIPLE SCLEROSIS MASQUERADING AS ALZHEIMER'S TYPE DEMENTIA: CLINICAL, RADIOLOGICAL, AND PATHOLOGICAL FINDINGS (2014) (0)
- IC-P2-146: Antemortem MRI-based structural abnormality index (STAND): Scores correlate with postmortem Alzheimer disease Braak stages (2008) (0)
- Seed-based characterization of intrinsic connectivity networks for distinguishing dementia (2011) (0)
- Superficial siderosis with predominant frontal lobe deposition in a person with Lewy body dementia (2013) (0)
- Effect of lifestyle activities on Alzheimer's biomarkers and cognition (2012) (0)
- O2-02-01 Patterns of atrophy on voxel based morphometry differ between amnestic MCI converters and nonconverters (2007) (0)
- Neuroimaging and neuropsychological findings in MAPT N279K mutation phenoconverters (2020) (0)
- Multimodality imaging differentiates dementia with lewy bodies from Alzheimer's disease (2011) (0)
- ANALYSIS OF IOFLUPANE-SPECT FINDINGS USING DATQUANT IN PATIENTS WITH IDIOPATHIC REM SLEEP BEHAVIOR DISORDER (2019) (0)
- Neuropsychiatric abnormalities in familial frontotemporal dementia: Findings from the LEFFTDS Cohort (2020) (0)
- Antemortem PiB binding correlates with postmortem amyloid density in a case with DLB on region of interest analysis (2010) (0)
- [18F]PI‐2620 PET in four‐repeat tauopathies: a preliminary study (2022) (0)
- Utility of ioflupane‐SPECT with multimodal imaging in dementia with Lewy bodies (2020) (0)
- Effects of beta-amyloid load on task-free fMRI abnormalities in dementia with Lewy bodies (2012) (0)
- Clinical-Imaging-Pathologic Analysis in Seven Patients with Dementia: Correlations with Ioflupane SPECT Findings (P6.236) (2016) (0)
- P1-046 Predictors of progression in amnestic MCI and multiple-domain MCI with memory impairment (2004) (0)
- Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy (2020) (0)
- DECODING GLUCOSE METABOLISM IN ALZHEIMER’S DISEASE REVEALS MACRO-SCALE BRAIN ORGANIZATION RELATED TO DISEASE EXPRESSION (2019) (0)
- APOE and quality of life in the oldest old (2009) (0)
- Hypometabolism in PiB-positive, population-based, cognitively normal subjects with and without APOE-ε4 (2013) (0)
- P1-304: Regional atrophy patterns associated with risk of future progression to Alzheimer's disease in amnestic mild cognitive impairment using a new time-to-event voxel based method (2008) (0)
- A NOVEL 18F-FDG PET-CT PATTERN IN IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS (2017) (0)
- Plasma AB levels as a premorbid biomarker for cognitive decline, mild cognitive impairment (MCI) and Alzheimer disease (AD) (2005) (0)
- PRINCIPAL AXES OF PHENOTYPIC VARIABILITY IN ALZHEIMER’S DISEASE DERIVED FROM AN FDG-PET BASED UNSUPERVISED MACHINE LEARNING ALGORITHM (2018) (0)
- Generating truth from error : insights from neurodevelopmental disorders (2018) (0)
- Gait Correlates of Cognitive Function and Future Decline (2022) (0)
- α-Synuclein in Red Blood Cells Is a Potential Diagnostic Biomarker for Parkinson’s Disease (1II-2.003) (2014) (0)
- PATHOLOGIC FEATURES IN TWENTY-TWO COGNITIVELY NORMAL ELDERLY SUBJECTS (1997) (0)
- PATTERN OF HYPOPERFUSION ON ASL OVERLAPS WITH HYPOMETABOLISM ON FDG-PET IN DEMENTIA WITH LEWY BODIES (2017) (0)
- Research Priorities of Individuals and Caregivers With Lewy Body Dementia (2023) (0)
- Initial Reports of ALLFTD Participant Internet and Social Media Usage Survey (2022) (0)
- VARIABILITY IN PDMN CONNECTIVITY AND RELATIVE HUBNESS IN COGNITIVELY NORMAL INDIVIDUALS PREDICT AMYLOID AND TAU DEPOSITION PATTERNS IN TYPICAL ALZHEIMER’S DISEASE (2018) (0)
- P3-018: Alzheimer's disease presenting as corticobasal syndrome (2008) (0)
- TRACKING WHITE MATTER DEGENERATION IN ASYMPTOMATIC AND SYMPTOMATIC MAPT MUTATION CARRIERS WITH DTI (2019) (0)
- Exploration of visual hallucinations – FDG‐PET associations in DLB and MCI‐LB with and without visual hallucinations (2022) (0)
- MRS differentiates people with MCI who progress to dementia with Lewy bodies from people who progress to Alzheimer's disease (2013) (0)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
- Association study of late-onset Alzheimer's disease risk variants and risk for posterior cortical atrophy (2013) (0)
- Clinical outcomes for stages of NIA-AA preclinical Alzheimer's disease (2012) (0)
- DaTscan Findings in Patients with Mild Cognitive Impairment, Alzheimer's Disease and Dementia with Lewy Bodies (IN3-1.008) (2013) (0)
- Erratum to: Network-driven plasma proteomics expose molecular changes in the Alzheimer’s brain (2016) (0)
- IC-P1-031: 11C PiB and structural magnetic resonance imaging in Mild Cognitive Impairment (2008) (0)
- Focus on Alzheimer's Disease and Related Disorders: A Review of the Non-Alzheimer Dementias (2006) (0)
- P-055 Longitudinal voxel based morphometry in AD: Optimizing the method to produce maps of gray matter change over time (2007) (0)
- Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures (2022) (0)
- P2-255 Do atrophy rates accelerate in MCI and normal aging? (2006) (0)
- Error in Byline. (2018) (0)
- FP-CIT SPECT and neuropathologic findings amongpatients with neurodegenerative syndromes from the Mayo Alzheimer’s Disease (2019) (0)
- Invited LecturesForum 12:30–14:00PD-MCI & PDD, DLB and ADChairperson: James Leverenz, USA1.11.1 MILD COGNITIVE IMPAIRMENT ASSOCIATED WITH UNDERLYING ALZHEIMER'S DISEASE VERSUS LEWY BODY DISEASE (2012) (0)
- O2-10-02 WHOLE EXOME SEQUENCING ANALYSIS IN EARLY ONSETALZHEIMER REVEALS NOVEL CANDIDATE GENES (2019) (0)
- Treatment Outcomes in REM Sleep Behavior Disorder (P05.022) (2013) (0)
- ELECTROPHYSIOLOGIC STUDIES IN CORTICAL BASAL GANGLIONIC DEGENERATION (CBGD) (1999) (0)
- Effects of β-amyloid Load on White Matter Integrity in Dementia with Lewy Bodies (P6.322) (2014) (0)
- Contents Vol. 14, 2002 (2002) (0)
- A 76 Year-Old Woman with Sleep and Waking Stridor, Sleep Talking, Orthostatic Hypotension, and Imbalance. (2016) (0)
- A Young Man With Progressive Language Difficulty and Early-Onset Dementia. (2016) (0)
- Anteromedial temporal lobe DTI and structural MRI changes in presymptomatic and symptomatic MAPT mutation carriers (2012) (0)
- Aberrant tau and amyloid pathology underlie 1H MR spectroscopic alterations in Alzheimer's disease and Lewy body disease (2013) (0)
- Frequency of TAR DNA‐binding protein 43 (TDP‐43) increases linearly with age in the demented and non‐demented elderly population (2022) (0)
- Corrigendum (2008) (0)
- TAU PET IMAGING CORRELATES WITH NEUROPATHOLOGY (2019) (0)
- EFFECTS OFAMYLOID PATHOLOGYAND HIPPOCAMPAL NEURODEGENERATION ON COGNITIVE CHANGE IN COGNITIVELY NORMAL OLDER ADULTS (2018) (0)
- Clinical, neuropsychiatric, and ioflupane SPECT imaging findings in REM sleep behavior disorder (2015) (0)
- Optimized ROI measures of FDG-PET improve characterization of early cognitive impairment and are comparable to PIB-PET (2011) (0)
- Your Questions Answered: LEWY BODY DEMENTIA (2007) (0)
- 1H MR Spectroscopy in Presymptomatic MAPT mutation carriers: A Biomarker for Tau Mediated Pathology (2010) (0)
- COMPARISON OF IOFLUPANE-SPECT FINDINGS USING DATQUANT IN PATIENTS WITH ALZHEIMER’S DISEASE DEMENTIA AND DEMENTIA WITH LEWY BODIES (2019) (0)
- FDG changes in PiB positive, cognitively normal subjects (2013) (0)
- IC-03-07: A voxel-based morphometry study correlating MRI with Braak neurofibrillary tangle stage at autopsy (2008) (0)
- An MRI-based strategy for differentiation of frontotemporal dementia and Alzheimer’s disease (2021) (0)
- ALTERED SLEEP-WAKE MECHANISMS IN NEURODEGENERATIVE DISEASE: SIMILARITIES AND DIFFERENCES BETWEEN LEWY BODY DISEASE AND NARCOLEPSY (2019) (0)
- An Investigation of White Matter Hyperintensities in Probable Dementia with Lewy Bodies (P6.235) (2016) (0)
- Characterization of Frontotemporal Dementia +/- Amyotrophic Lateral Sclerosis Associated with the GGGGCC Repeat Expansion in C9ORF72 (S54.005) (2012) (0)
- MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features (2020) (0)
- ARE PLASMA Aβ MEASURES ASSOCIATED WITH LONGITUDINAL CHANGE IN HIPPOCAMPAL VOLUME? (2014) (0)
- Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures (2022) (0)
- 094 ASSESSMENT OF DYNAMIC GAIT ANALYSIS BETWEEN AMNESTIC AND NON-AMNESTIC MILD COGNITIVE IMPAIRMENT (2010) (0)
- Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (2020) (0)
- 0640 North American Prodromal Synucleinopathy Consortium: Baseline characteristics in 251 patients with REM Sleep Behavior Disorder (2022) (0)
- NON-AD DEMENTIAS: ALPHA-SYNUCLEINOPATHIES (2017) (0)
- Latent space projection of brain FDG‐PET creates a powerful classifier for neurodegenerative diseases (2022) (0)
- P2-185 Glucose metabolic patterns in amnestic mild cognitive impairment and Alzheimer's disease; an FDG pet study (2004) (0)
- Sleep and circadian rhythm disorders (2020) (0)
- P3-078 Brain atrophy rate measures correlate with subsequent clinical course in normal and impaired elderly subjects (2004) (0)
- Frequency and distribution of cerebral microbleeds in dementia with lewy bodies (2015) (0)
- 0269 Non-REM sleep Hypertonia in Parkinsonian-Spectrum Disorders (2022) (0)
- STRUCTURAL EQUATION MODELLING REVEALS A DIRECT AND INDIRECT EFFECT OF APOE ε4 ON TAR DNA BINDING PROTEIN 43 (2018) (0)
- Cognitive Performance Correlates with Resting State Connectivity and is Effected by APOE Status (2010) (0)
- ENTORHINAL CORTEX TAU PET, CORTICAL THICKNESS AND MEMORY PERFORMANCE IN COGNITIVELY UNIMPAIRED PERSONS (2018) (0)
- CONTINUOUS MEASURES OF β-AMYLOIDOSIS AND CORTICAL THICKNESS IN RELATION TO COGNITIVE DECLINE IN COGNITIVELY NORMAL INDIVIDUALS: A POPULATION-BASED STUDY (2017) (0)
- ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans (2018) (0)
- P1-106 Neuropsychological differentiation of dementia with Lewy bodies and Alzheimer's disease (2004) (0)
- CORTICAL MICROINFARCTS AND REGIONAL GRAY MATTER LOSS ON ANTEMORTEM MRI (2016) (0)
- BRAIN STATES AND TAU PET PATTERNS INTERACT ACROSS THE AGING-ALZHEIMER’S CONTINUUM (2019) (0)
- APOE4 allele frequency in frontotemporal lobar degeneration (2000) (0)
- P2-299 FMRI activation patterns during encoding and recognition in normal elderly and amnestic mild cognitive impairment patients (2006) (0)
- Association of Type 2 Diabetes Cognitive Impairment is Mediated by Brain Atrophy (S58.005) (2014) (0)
- Cingulate Hypoperfusion Is a Common Feature of the Familial Fronto-Temporal Dementias (P05.064) (2012) (0)
- Impairment in the maintenance of wakefulness is objectively demonstrated in patients with dementia with lewy bodies (2011) (0)
- NOMENCLATURE OF PAROXYSMAL SYMPATHETIC STORMS . AUTHORS' REPLY (1999) (0)
- Reduced Slow-Wave Sleep and Severe Sleep Apnea are Associated with Neuroimaging Biomarkers of Cerebrovascular Disease (S6.004) (2023) (0)
- REM Sleep without Atonia Severity Predicts Cognitive Impairment in REM Sleep Behavior Disorder (P7.307) (2015) (0)
- P2-214 Is manual editing necessary for boundary shift integral measurements? (2004) (0)
- ELECTROENCEPHALOGRAM FINDINGS IN PATIENTS WITH POSTERIOR CORTICAL ATROPHY (2018) (0)
- Differentiation of bvFTD and Alzheimer's disease using grey matter DTI and volume measurements (2010) (0)
- Does Circadian-Activity-Rhythm Architecture Predict Future Cognitive Decline? (2011) (0)
- Multimodal imaging in familial FTLD: phenoconversion and planning for the future. (2019) (0)
- Frequency of cerebral infarcts in probable dementia with lewy bodies (2015) (0)
- SelectiveWorsening of Brain Injury Biomarker Abnormalities in Cognitively Normal Elderly PersonsWith β-Amyloidosis (2013) (0)
- STRUCTURAL EQUATION MODELLING REVEALS A DIRECT AND INDIRECT EFFECTOFAPOE ε 4ONTARDNABINDING PROTEIN 43 (2018) (0)
- An enrichment of rare variants and the lysosomal pathways are important contributors to early onset Alzheimer disease (2021) (0)
- FDG PET, Aging and APOE Genotype in Cognitively Normal Persons (S8.006) (2014) (0)
- P1-308: A voxel-based morphometry study correlating MRI with Braak neurofibrillary tangle stage at autopsy (2008) (0)
- Clinical value of CSF tau, p‐tau181, neurogranin and neurofilaments in familial frontotemporal lobar degeneration (2021) (0)
- Characteristics, caregiver evaluations, and telephone call volume of a frontotemporal dementia caregiver educational and support program (2015) (0)
- P1-367 COMPARISON OF IOFLUPANE-SPECT FINDINGSUSINGDATQUANT IN PATIENTS WITHALZHEIMER’S DISEASEDEMENTIA AND DEMENTIAWITH LEWY BODIES (2019) (0)
- An autoradiographic evaluation of AV-1451 Tau PET in dementia (2016) (0)
- P3-102 Annualized decrease in plasma Aβ42 correlates with annualized decrease in hippocampal volume (2006) (0)
- 104. Broad clinical spectrum of voltage-gated gotassium channel autoimmunity (2009) (0)
- Cognition and driving ability in isolated and symptomatic REM sleep behavior disorder. (2022) (0)
- 528 REM Sleep Without Atonia in Idiopathic REM Sleep Behavior Disorder in the North American Prodromal Synucleinopathy Cohort (2021) (0)
- Mild cognitive impairment associated with eventual Lewy body disease pathology: Clinical characterization of 75 patients (2019) (0)
- Optimizing software methods for measuring flortaucipir SUVR change over time (2021) (0)
- ALLFTD Mobile App Balance and Finger Tapping Tasks: Task Description and Initial Reliability and Validity Findings (2022) (0)
- IN56-TH-02 The overlap syndromes (2009) (0)
- Stability of the diagnosis of mild cognitive impairment (2010) (0)
- O1-02-03: Antemortem MRI–based structural abnormality index (STAND) scores correlate with postmortem Alzheimer disease Braak stages (2008) (0)
- IC-102-04 1H MR spectroscopy findings differ among mild cognitive impairment syndromes (2006) (0)
- Cognition and Driving Ability in Isolated and Symptomatic REM Sleep Behavior Disorder. (2021) (0)
- Effect of Amyloid-Beta load on cognition is modified by the APOE status in a population-based sample of cognitively normal older adults (2011) (0)
- Presymptomatic and symptomatic MAPT mutation carriers feature functional connectivity alterations (2021) (0)
- biomarkers DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and (2007) (0)
- LONGITUDINAL ACCUMULATION OF β-AMYLOID ON PET IN DEMENTIA WITH LEWY BODIES AND RELATIONSHIP TO CLINICAL DISEASE PROGRESSION (2018) (0)
- Demographic and psychosocial factors associated with the decision to learn mutation status in familial frontotemporal dementia and the impact of disclosure on mood (2021) (0)
- tau-PET signal elevation in selective basal forebrain nuclei is associated with excessive daytime sleepiness in cognitively unimpaired middle aged and older adults (2019) (0)
- Dramatic improvement with donepezil in a case of dementia with Lewy bodies (2013) (0)
- Subject Index Vol. 27, 2009 (2009) (0)
- Evidence of cerebellar TDP-43 loss of function in FTLD-TDP (2022) (0)
- Sleep disorders in older people (2008) (0)
- PET TAU IMAGING WITH AV-1451 IN MICROTUBULE-ASSOCIATED PROTEIN TAU (MAPT) MUTATION CARRIERS RELATIVE TO ALZHEIMER’S DISEASE DEMENTIA AND CONTROLS (2016) (0)
- O4-04-02 The cognitive subtypes of mild cognitive impairment in a population-based study (2006) (0)
- Educational Attainment in Patients with Frontotemporal Dementia and Primary Progressive Aphasia Compared to Other Dementia Syndromes (P03.089) (2013) (0)
- PLASMA PTAU181 LEVELS REFLECT [18F]AV1451 TAU PET UPTAKE ACROSS THE TAUOPATHY SPECTRUM (2019) (0)
- Serial Evaluation of PiB Accumulation in White Matter (2016) (0)
- THE LEWY BODY DEMENTIA ASSOCIATION RESEARCH CENTERS OF EXCELLENCE PROGRAM: TOWARD OPTIMIZING CLINICAL CARE AND CLINICAL TRIAL INFRASTRUCTURE (2018) (0)
- Optimum Differentiation of Frontotemporal Lobar Degeneration from Alzheimer Disease Achieved with Cross‐Sectional Tau Positron Emission Tomography (2022) (0)
- Disease progression models of familial frontotemporal lobar degeneration and the temporal ordering of biomarker changes in an international cohort (2021) (0)
- Clinical presentation and pharmacological therapy in cortico-basal ganglionic degeneration (1996) (0)
- P1-224 Population-based prevalence of mild cognitive impairment (2006) (0)
- The Advancing Research and Treatment in Frontotemporal Lobar Degeneration (ARTFL) North American Rare Disease Clinical Research Consortium: Progress and Participant Characterization (S2.008) (2018) (0)
- 0635 Validation of a clinical scale for defining RBD severity in participants of the North American Prodromal Synucleinopathy (NAPS) consortium (2022) (0)
- Major Depression As Initial Manifestation Of Limbic Lewy Body Dementia A Clinico-Pathological Report (P2.155) (2014) (0)
- P4-161 The Lewy body variant of posterior cortical atrophy (2006) (0)
- Isolated rapid eye movement sleep behaviour disorder: clinical and research implications (2023) (0)
- P-045 Amnestic MCI: Regional differences exist between deficits in structure and function during semantic decision making (2007) (0)
- Potential utility of longitudinal 123I‐FP‐CIT SPECT imaging in predicting phenoconversion to overt synucleinopathy in isolated REM sleep behavior disorder (2021) (0)
- Effect of APOE4 status and Alzheimer's disease on posterior cingulate connectivity (2010) (0)
- Hippocampal volume and depressive symptoms: A population-based neuroimaging study (2009) (0)
- Plasma Neuro fi lament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration (0)
- Contents Vol. 27, 2009 (2009) (0)
- Characterization of CDR® plus NACC FTLD at Phenoconversion from Asymptomatic to Mild Behavioral and/or Cognitive Impairment in Familial Frontotemporal Lobar Degeneration: Data from the ALLFTD Consortium (2022) (0)
- Orthostatic Hypotension as a Prodromal Marker of α-Synucleinopathies-Reply. (2018) (0)
- Nonlinear and Non-Monotonic Relationship between Default Mode Network Connectivity and Hippocampal Volumes across the ADNI Cohort Cross-Sectionally and Longitudinally (P06.025) (2013) (0)
- P2-345 1H MR spectroscopy findings differ among mild cognitive impairment syndromes (2006) (0)
- Baseline characteristics of the North American prodromal Synucleinopathy cohort (2023) (0)
- PATHOLOGIC PREDICTORS OF DISEASE DURATION IN LEWY BODY DISEASE (2016) (0)
- Clinical evaluation of AV-138 for PET amyloid imaging (2008) (0)
- Atlas of Clinical Neurology (1998) (0)
- P-041 1H MR spectroscopy markers of cardiovascular risk factors in non-demented elderly (2007) (0)
- FRONTOTEMPORAL LOBAR DEGENERATION RESEARCH IN NORTH AMERICA: PROGRESS IN THE ARTFL/LEFFTDS CONSORTIA (2019) (0)
- CD33, MEF2C, and SORL1 are associated with variability in macroscale functional brain architecture in AD (2020) (0)
- Baseline and Longitudinal Ioflupane SPECT Findings in DLB and MCI‐LB (2022) (0)
- Combinations of amyloid and neurodegeneration biomarkers have a differential impact on cognition (2013) (0)
- Temporoparietal hypometabolism is common in FTLD and is associated with imaging diagnostic errors (2011) (0)
- IC-P-024 MRI, MRS and clinical correlates in posterior cortical atrophy and typical Alzheimer’s disease (2006) (0)
- Clinical features in prodromal disease: Comparing dementia with Lewy bodies with Alzheimer’s disease (2022) (0)
- ANALYSIS OF IOFLUPANE-SPECT FINDINGS USING DATQUANT IN PATIENTS WITH IDIOPATHIC REM SLEEP BEHAVIOR DISORDER (2019) (0)
- Seed-based characterization of intrinsic connectivity networks for distinguishing dementia (2011) (0)
- Progression of Cerebral Atrophy and Hypometabolism in the presence of β-amyloidosis in mild cognitive impairment (S41.007) (2015) (0)
- CogState computerized testing is associated with amyloid and FDG-PET: Implications for secondary preventive trials (2013) (0)
- QUALITY OF LIFE AMONG SUBJECTS AND INFORMANTS IN FAMILIAL FRONTOTEMPORAL DEMENTIA: PRELIMINARY DATA IN THE LEFFTDS COHORT (2017) (0)
- Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials (2020) (0)
- ANALYSIS OF IOFLUPANE-SPECT FINDINGS USING DATQUANT IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT (2019) (0)
- Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias (2023) (0)
- Longitudinal evaluation of familial frontotemporal dementia subjects (LEFFTDS): Subject characteristics, aims, and methodology (2015) (0)
- P3-271: Association of candidate gene susceptibility alleles on chromosome 10 with Alzheimer's disease risk and endophenotypes (2008) (0)
- Cognitive Endophenotype Associated with the C9ORF72 GGGGCC Expansion in FTD/ALS (P05.063) (2012) (0)
- Frequency and distribution of cerebral microbleeds in dementia with lewy bodies (2015) (0)
- DATSCAN FINDINGS IN PATIENTS WITH REM SLEEP BEHAVIOR DISORDER AND/OR COGNITIVE IMPAIRMENT (2014) (0)
- A remote smartphone cognitive testing battery for frontotemporal dementia: Completion rate, reliability, and validity (2021) (0)
- IC-P-019 LONGITUDINAL ACCUMULATION OF b AMYLOID ON PET IN DEMENTIAWITH LEWY BODIES AND RELATIONSHIP TO CLINICAL DISEASE PROGRESSION PREDICTING RESILIENCYAGAINST AMYLOID-BETA DEPOSITION, COGNITIVE IMPAIRMENT, AND THEIR COMBINATION IN THE OLDEST-OLD (2018) (0)
- IC-P-082 TAU AND ALPHA-SYNUCLEIN SELECTIVE BINDING COMPOUNDS DERIVED FROM APRINOIATHERAPEUTIC’S PM-PBB3 BINDING-SITE FOCUSED COMPOUND COLLECTION (2018) (0)
- 0557 Diagnostic Visual and Automated Polysomnagraphic REM Sleep Without Atonia Thresholds in Isolated REM Sleep Behavior Disorder 2.0 (2022) (0)
- Parkinsonism-Related Dementiasa (2015) (0)
- A high burden of vascular disease increases the risk of mild cognitive impairment: the mayo clinic study of aging. (2011) (0)
- Poster Presentations: P2 P391 P2-124 ABERRANT TAU AND AMYLOID PATHOLOGY UNDERLIE 1H MR SPECTROSCOPIC ALTERATIONS IN ALZHEIMER’S DISEASE AND LEWY BODY DISEASE (2013) (0)
- Hippocampal volume and depressive symptoms: a population-based neuroimaging study (2009) (0)
- PATHOLOGIC INVESTIGATION OF MICROINFARCTS AND ASSOCIATION WITH GRAY MATTER ATROPHY ON ANTEMORTEM MRI (2014) (0)
- CHARACTERIZATION OF THE CLINICAL AND NEUROIMAGING FEATURES OF PATIENTS WITH DEMENTIA WITH LEWY BODIES ASSOCIATED WITH VARIANTS IN GLUCOCEREBROSIDASE (GBA) (2017) (0)
- The evolution of brain atrophy across the disease spectrum of familial frontotemporal dementia (2020) (0)
- ANTEMORTEM VOLUME LOSS MIRRORS TDP43 STAGING IN NON-FTLD OLDER ADULTS (2019) (0)
- Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel (2023) (0)
- MR elastography of frontotemporal dementia (2013) (0)
- Brain glucose metabolism and nigrostriatal degeneration in isolated rapid eye movement sleep behaviour disorder (2023) (0)
- Differentiation of bvFTD and Alzheimer's disease Using Grey Matter DTI and Volume Measurements (2010) (0)
- Clinical features in a kindred with familial frontotemporal dementia with the P301L tau mutation (2000) (0)
- The Accuracy and Reliability of Sleep Staging and Sleep Biomarkers in Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder (2023) (0)
- Vascular risk factors are associated with a reduced brain volume: The mayo clinic study of aging (2009) (0)
- Sex differences in grey matter networks in dementia with Lewy bodies (2023) (0)
- P2-348 MRI, MRS and clinical correlates in posterior cortical atrophy and typical Alzheimer’s disease (2006) (0)
- P1-289: Tensor based morphometry test retest validation in Alzheimer's disease subjects (2008) (0)
- CHAPTER 70 – DEMENTIA WITH LEWY BODIES (2007) (0)
- Different anatomical subtypes of behavioral variant frontotemporal dementia identified using cluster analysis (2009) (0)
- Characteristics of REM Sleep Behavior Disorder Affect the Risk of Developing an Overt Synucleinopathy (P6-13.005) (2023) (0)
- REGIONAL TAU-PET UPTAKE PATTERNS AND THEIR ASSOCIATION WITH BRAAK STAGING, COGNITION, AND ONSET OF AD-DEMENTIA (2016) (0)
- USING A BRAIN NETWORK APPROACH TO PREDICT GENETIC MUTATION IN INDIVIDUAL PATIENTS WITH FAMILIAL FRONTOTEMPORAL DEMENTIA (2018) (0)
- AV1451 PET IMAGING IN THE SPECTRUM OF ALZHEIMER’S DISEASE FROM CLINICALLY NORMAL TO DEMENTIA (2016) (0)
- 524 NAPS (0)
- P4-187 Compensating for memory loss in amnestic mild cognitive impairment (2006) (0)
- Continued Validation of the RBD Symptom Severity Scale (RBDSSS) in Participants of the North American Prodromal Synucleinopathy (NAPS) Consortium (P6-13.004) (2023) (0)
- Introduction to Veri‐T: A Phase 1 Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Trial of Verdiperstat in Patients with svPPA Due to FTLD‐TDP (2022) (0)
- IC-P-007 fMRI activation patterns during encoding and recognition in normal elderly and amnestic mild cognitive impairment patients (2006) (0)
- P4-148 Genetic analyses of a family with frontotemporal dementia (2004) (0)
- Prospective NCCTG quality of life (QOL) study in adult newly diagnosed high-grade gliomas (HGG). (2004) (0)
- Latent disease models estimate symptom onset in familial frontotemporal lobar degeneration and enable novel designs for early‐stage clinical trials (2020) (0)
- TDP-43 IN ATYPICAL ALZHEIMER’S DISEASE DEMENTIA (2018) (0)
- APOE Allele Testing and Alzheimer Disease-Reply. (2021) (0)
- Prominent Auditory Hallucinations in Behavioral Variant Frontotemporal Dementia Associated with a MAPT Mutation (P3.1-006) (2019) (0)
- APATHY AND REDUCED STRIATAL UPTAKE IN DEMENTIA WITH LEWY BODIES (2014) (0)
- ADVANCING RESEARCH AND TREATMENT IN FRONTOTEMPORAL LOBAR DEGENERATION (ARTFL) NORTH AMERICAN RARE DISEASE CLINICAL RESEARCH CONSORTIUM: PROGRESS AND CHARACTERIZATION OF INITIAL PARTICIPANTS (2017) (0)
- Effect of APOE4 Status and Alzheimer's Disease on Posterior Cingulate Connectivity (2010) (0)
- Hypometabolism in PiB-positive, population-based, cognitively normal subjects with and without APOE-ɛ4 (2013) (0)
- Dual pathologies: utility of TAR DNA-binding protein 43 (TDP-43) staining in patients with frontal and temporal lobe abnormalities and Alzheimer disease: 41.3 (2007) (0)
- P4-150 Neuropsychological findings in mild frontotemporal dementia associated with tau mutations (2004) (0)
- PATHOLOGIC INVESTIGATION OF MICROINFARCTS AND ASSOCIATION WITH GRAY MATTER ATROPHY ON ANTEMORTEM MRI (2014) (0)
- Cancer survivors have a lower frequency of dementia in the 95+ oldest‐old (2021) (0)
- 0266 Sleep Spindle-Duration: A Potential Biomarker for Neurodegenerative Disorder Phenotyping (2022) (0)
- The Incidence and Prevalence of Autoimmune Encephalitis and a comparison to Infectious Encephalitis: A Population-Based Study (P5.401) (2018) (0)
- Clinical features that differentiate young‐onset AD from young‐onset FTLD: An examination of the NACC UDS 3.0 and FTLD Module (2021) (0)
- Antemortem MRI findings associated with presence of microinfarcts at autopsy (2013) (0)
- MAPT haplotypes modify the association between head injury and risk of Alzheimer’s disease (2015) (0)
- O1-04-08 PIB and MRI provide complementary information in imaging of AD and MCI (2007) (0)
- TDP-43 in Alzheimer’s Disease Is Not Associated with Parkinsonian Features or Clinical FTD (P4.206) (2014) (0)
- MR elastography of frontotemporal dementia (2013) (0)
- IC-02-05 GENDER DIFFERENCES IN THE ASSOCIATION BETWEEN LONGITUDINAL BRAIN CHANGES AND BASELINE LEVELS OF CSFALZHEIMER’S DISEASE AND GLIAL BIOMARKERS IN HEALTHY ELDERS (2019) (0)
- Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene (2014) (0)
- Data from: Longitudinal structural and metabolic changes in frontotemporal dementia (2021) (0)
- P-065 Characterization of MCI using patterns of atrophy recognized by a support vector machine (2007) (0)
- P1-161: 11C PiB and structural magnetic resonance imaging in mild cognitive impairment (2008) (0)
- Evolution of core features in Lewy body disease pathologic subtypes (2021) (0)
- Systems fail before molecules spread: A cascading failure model of Alzheimer’s disease (2015) (0)
- Global functional connectivity changes in Alzheimer's disease (2010) (0)
- Dementia with Lewy bodies: Frequency in a community-based autopsy series and accuracy of the clinical diagnostic criteria (2000) (0)
- PATTERN OF AV-1451 UPTAKE IN DEMENTIA WITH LEWY BODIES AND ITS ASSOCIATION WITH AMYLOID-BETA DEPOSITION (2016) (0)
- Diagnostic value of plasma P‐tau217 in frontotemporal dementia spectrum disorders (2021) (0)
- TAR DNA‐binding protein 43 (TDP‐43) contributes to the mismatch between medial temporal volumes and flortaucipir uptake in elderly patients with Alzheimer’s disease neuropathologic changes (2022) (0)
- Infarctions on antemortem MRI are associated with the presence of microinfarcts at autopsy (2012) (0)
- CHARACTERISTICS AND PROGRESS OF 320 SUBJECTS IN THE LONGITUDINAL EVALUATION OF FAMILIAL FRONTOTEMPORAL DEMENTIA SUBJECTS (LEFFTDS) PROTOCOL (2018) (0)
- IC-P1-034: Neuropathological correlates of antemortem 1H MR spectroscopy in Alzheimer's disease (2008) (0)
- CLINICAL FEATURES, CSF BIOMARKERS, MOLECULAR IMAGING, AND PATHOLOGY IN DYSEXECUTIVE ALZHEIMER’S DISEASE (2018) (0)
- Frequency of cerebral infarcts in probable dementia with lewy bodies (2015) (0)
- P1-195: Functional magnetic resonance imaging activation patterns in cognitively normal elderly, amnestic, and non-amnestic mild cognitive impairment during a recognition memory task (2008) (0)
- Gearing up for the future: Exploring facilitators and barriers to inform clinical trial design in frontotemporal lobar degeneration (2021) (0)
- P3-173 Apolipoprotein E frequency in posterior cortical atrophy and typical Alzheimer’s disease (2006) (0)
- THE MULTIDOMAIN IMPAIRMENT RATING (MIR) SCALE: INITIAL RELIABILITY DATA ON A MULTIDIMENSIONAL SCALE DESIGNED FOR FTLD SPECTRUM DISORDERS (2019) (0)
- COMPLEXITIES OF LEWY BODY DISEASE (2014) (0)
- A Comparison of Network Connectivity and Atrophy Patterns in Behavioral Variant Frontotemporal Dementia (2010) (0)
- IC-P-064 ANALYSIS OF IOFLUPANE-SPECT FINDINGSUSINGDATQUANT IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT (2019) (0)
- REM Sleep Behavior Disorder Is Associated with Reduced Alzheimer's Pathology, Hippocampal and Parietotemporal Atrophy in Dementia with Lewy Bodies (S44.006) (2013) (0)
- Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2017) (0)
- Automated index of semantic verbal fluency in mild cognitive impairment and Alzheimer's disease (2012) (0)
- IC-P-064 ANALYSIS OF IOFLUPANE-SPECT FINDINGSUSINGDATQUANT IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT (2019) (0)
- Behavioral Variant Frontotemporal Dementia (2020) (0)
- population-based sample MRI and MRS predictors of mild cognitive impairment in a (0)
- ACCELERATED NEUROCHEMICAL CHANGES PRIOR TO PHENOCONVERSION TO FRONTOTEMPORAL LOBAR DEGENERATION IN PRESYMPTOMATIC MICROTUBULE-ASSOCIATED PROTEIN TAU (MAPT) MUTATION CARRIERS: A LONGITUDINAL MRS STUDY (2018) (0)
- Quantitative susceptibility mapping of substantia nigra in dementia with Lewy bodies (2020) (0)
- LONGITUDINAL CHANGES IN BRAIN MRI AND NEUROPSYCHOMETRICS IN ASYMPTOMATIC AND SYMPTOMATIC FAMILIAL FRONTOTEMPORAL LOBAR DEGENERATION WITH MUTATIONS IN MAPT (2014) (0)
- Novel associations of BST1 and LAMP3 with rapid eye movement sleep behavior disorder (2020) (0)
- 0555 Isolated REM Sleep Without Atonia Following COVID-19 Infection: A Case-Control Study (2022) (0)
- Dementia at the bedside (2016) (0)
- REM sleep without atonia predicts cognitive impairment in REM sleep behavior disorder (2015) (0)
- 027 SLOW GAIT PREDICTS INCIDENT MCI IN A POPULATION-BASED COHORT: THE MAYO CLINIC STUDY OF AGING (2010) (0)
- MILD COGNITIVE IMPAIRMENT PROGRESSING TO DEMENTIA WITH LEWY BODIES: REGIONAL ATROPHY RATES AND RELATIONSHIP TO AV-1451 UPTAKE (2019) (0)
- Complement and NfL associations with brain structure and functional connectivity alterations in presymptomatic and symptomatic GRN mutation carriers (2021) (0)
- COMPARISON OF 123I-FP-CIT SPECT THREE QUANTIFICATION METHODS: A CLINICOPATHOLOGIC ANALYSIS IN 23 PATIENTS (2019) (0)
- atrophy and posterior AD Late-onset Alzheimer disease genetic variants in posterior cortical (0)
- O3-06-06: Patterns of regional change over time in the syndromic variants of frontotemporal dementia and Alzheimer's disease (2008) (0)
- Multilocus genotype pattern at PICALM, CLU and APOE genes is associated with episodic memory in the NIA-LOAD/NCRAD study (2011) (0)
- IC-P-067 Patterns of decreased glucose metabolism differ among younger and older mild cognitive impairment patients; an FDG PET study (2006) (0)
- 11C-PiB PET and hippocampal volumes are complementary in distinguishing dementia with Lewy bodies and Alzheimer's disease (2009) (0)
- Disrupted brain dynamics across the Alzheimer’s disease spectrum is related to tau accumulation (2020) (0)
- Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers (2019) (0)
- P2-198 Patterns of decreased glucose metabolism differ among younger and older mild cognitive impairment patients; an FDG PET study (2006) (0)
- 0650 Normative EMG Values and Isolated Rapid Eye Movement Sleep Without Atonia Frequency in Adults without REM Sleep Behavior Disorder (2019) (0)
- 1021 Cognitive, Motor, and Autonomic Function Impairments in Idiopathic REM Sleep Behavior Disorder (2018) (0)
- Similar maximal educational attainment in people with dementia: Association with pathologically diagnosed frontotemporal lobar degeneration, Alzheimer's disease and Lewy body disease? (2013) (0)
- Antemortem Characterization of a Kindred Carrying the Non-Coding GGGGCC Hexanucleotide Repeat Expansion in C9ORF72 (IN9-1.009) (2012) (0)
- ANALYSIS OF IOFLUPANE-SPECT FINDINGS USING DATQUANT IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT (2019) (0)
- The Neurofilament Surveillance Project (NSP): A biomarker study to sample blood quarterly in familial frontotemporal lobar degeneration (2022) (0)
- Association between TDP-43 type and cognitive resilience to Alzheimer’s disease: a case-control study (2020) (0)
- Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia (2018) (0)
- RBD Is Associated with Reduced Alzheimer's Pathology in Dementia with Lewy Bodies (P05.050) (2012) (0)
- 1H MR spectroscopy in presymptomatic MAPT mutation carriers: A biomarker for tau mediated pathology (2010) (0)
- Diagnostic yield of rem sleep muscle activity for presumed synucleinopathy neurodegeneration (2019) (0)
- Predicting amyloid PET and tau PET stages with plasma biomarkers (2023) (0)
- Event‐related‐potentials are sensitive and reliable EEG biomarkers for mild cognitive impairment: A longitudinal study (2022) (0)
- SLEEP-RELATED FEATURES AND PERFORMANCE ON A COMPUTERIZED COGNITIVE BATTERY: THE MAYO CLINIC STUDY OF AGING (2014) (0)
- FDG-PET and PiB-PET imaging in asymptomatic at-risk carriers of a novel octapeptide repeat insertion in PRNP (2013) (0)
- Impact of Armodafinil Therapy on Neuropsychiatric Features in Dementia with Lewy Bodies (S1.004) (2016) (0)
- Default mode network failure and neurodegeneration across aging and amnestic and dysexecutive Alzheimer’s disease (2023) (0)
- HLA in isolated REM sleep behavior disorder and Lewy body dementia (2023) (0)
- Apathy and depression in mild cognitive impairment and the outcome of dementia: The Mayo Clinic Study of Aging (2010) (0)
- Clinical Characteristics of Parkinsonism in Frontotemporal Dementia Syndromes Associated with Mutations in MAPT, PGRN, C9ORF72 (P06.075) (2012) (0)
- A Kindred with Familial Frontotemporal Dementia and/or Amyotrophic Lateral Sclerosis Associated with the GGGGCC Repeat Expansion in C9ORF72 (P05.058) (2012) (0)
- DATSCAN FINDINGS IN PATIENTS WITH REM SLEEP BEHAVIOR DISORDER AND/OR COGNITIVE IMPAIRMENT (2014) (0)
- P1-164: Hippocampal volumes: 1HMR spectroscopy metabolites and cerebrovascular disease in mild cognitive impairment subtypes (2008) (0)
- Cognitive and behavioral features of c9FTD/ALS (2012) (0)
- Optimized ROI measures of FDG—PET improve characterization of early cognitive impairment and are comparable to PIB—PET (2011) (0)
- Assessing the needs of Black/African American dementia caregivers seeking emotional support (2021) (0)
- A Family With Corticobasal Degeneration, Parkinson’s Disease, Amyotrophic Lateral Sclerosis, and Dementia (P3.085) (2014) (0)
- COMPARISON OF 123I-FP-CIT SPECT THREE QUANTIFICATION METHODS: A CLINICOPATHOLOGIC ANALYSIS IN 23 PATIENTS (2019) (0)
- THE NIH-EXAMINER IS SENSITIVE TO COGNITIVE CHANGES IN ASYMPTOMATIC AND MILDLY SYMPTOMATIC FAMILIAL FRONTOTEMPORAL DEMENTIA (2018) (0)
- Pilot quantitative analyses of rem sleep without atonia in children and adolescents with rem sleep behavior disorder (2013) (0)
- P3-366 Neuropsychiatric inventory: comparison between corticobasal syndrome and Alzheimer's disease (2004) (0)
- REPURPOSING FDG-PET AS A DIAGNOSTIC TOOL FOR ALZHEIMER’S-RELATED TDP-43-PROTEINOPATHY (2019) (0)
- Erratum to: REM Sleep Behavior Disorder and REM Sleep Without Atonia as an Early Manifestation of Degenerative Neurological Disease (2012) (0)
- Antemortem hippocampal atrophy on MRI predicts presence of Alzheimer's disease pathology in pathologically confirmed Lewy body disease (2011) (0)
- P3-339 Longitudinal characterization of two siblings with frontotemporal dementia associated with the S305N tau mutation (2004) (0)
- LONGITUDINAL PERFORMANCE ON THE KING DEVICK TEST IN PATIENTS WITH REM SLEEP BEHAVIOR DISORDER +/- MILD COGNITIVE IMPAIRMENT (2017) (0)
- Progression of white matter signal abnormalities in predementia frontotemporal dementia mutation carriers (2022) (0)
- P1-255: Neuropathological correlates of antemortem 1H MR spectroscopy in Alzheimer's disease (2008) (0)
- An examination of atypical primary progressive aphasia variants (2021) (0)
- Network-driven plasma proteomics expose molecular changes in the Alzheimer’s brain (2016) (0)
- THE CLINICAL SPECTRUM OF FRONTOTEMPORAL LOBAR DEGENERATION IN NORTH AMERICA: BASELINE CHARACTERISTICS OF THE FIRST 912 PARTICIPANTS FROM THE ADVANCING RESEARCH AND TREATMENT IN FTLD (ARTFL) CLINICAL RESEARCH CONSORTIUM (2018) (0)
- Development of a robust MRI metric for longitudinal studies in Alzheimer's disease (2012) (0)
- 2.321 Do chronic non-specific brain insults predispose to incidental Lewy Body Disease? An exploratory study (2007) (0)
- Rapid Eye Movement Sleep Behavior Disorder (2017) (0)
- IC-P3-225: Regional atrophy patterns associated with risk of future progression to AD in amnestic MCI using a new time-to-event voxel based method (2008) (0)
- MRI and MRS predictors of MCI in a population-based sample of cognitively normal older adults (2012) (0)
- Functional connectivity is associated with tau spreading in dementia with Lewy bodies (2020) (0)
- O2-02-07 Hippocampal diffusivity on DTI differ between amnestic and non-amnestic MCI (2007) (0)
- P1-165: Association of prior stroke with mild cognitive impairment: A population-based study (2008) (0)
- ANTE-MORTEM VOLUME LOSS MIRRORS TDP43 STAGING IN NON-FTLD OLDER ADULTS (2019) (0)
- Quantitative analyses of REM sleep without atonia in patients with voltage gated potassium channel antibody syndrome (2015) (0)
- P4-159 Neuropathology of mild cognitive impairment evolving into clinically probable dementia with Lewy bodies (2006) (0)
- IC-P2-154: Patterns of regional change over time in the syndromic variants of frontotemporal dementia and Alzheimer's disease (2008) (0)
- Baseline Reliability and Six‐Month Stability of a Remotely Administered Battery of Smartphone Cognitive Tests (2022) (0)
- Cognitive Performance Correlates with Resting State Connectivity and is Effected by APOE Status (2010) (0)
- The Dementias, John H. Growdon, Martin N. Rossor (Eds.). Butterworth-Heinemann (telephone: 800-366-2665), Newton, Massachusetts (1998), 441, with illus, $95, ISBN: 0-7506-9920-5 (1999) (0)
- Contents Vol. 43, 2017 (2017) (0)
- Characterization of the Neuropsychiatric Features Associated with Mutations in C9ORF72' MAPT and PGRN (P05.065) (2012) (0)
- RESOURCE OF MULTIPLEX AFRICAN AMERICAN FAMILIES FOR WHOLE-GENOME SEQUENCING (2017) (0)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) (0)
- Abnormal daytime sleepiness in dementia with Lewy bodies compared to Alzheimer’s disease using the Multiple Sleep Latency Test (2014) (0)
- The Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS) Protocol: Known Kindreds and Preliminary Data (P5.003) (2015) (0)
- Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meeting (2021) (0)
- LONGITUDINAL ACCUMULATION OF β-AMYLOID ON PET IN DEMENTIA WITH LEWY BODIES AND RELATIONSHIP TO CLINICAL DISEASE PROGRESSION (2018) (0)
- The many faces of globular glial tauopathy: A clinical and imaging study (2022) (0)
- MRI and MRS predictors of MCI in a population-based sample of cognitively normal older adults (2012) (0)
- Regional and whole-brain atrophy rates in autopsy-confirmed dementia with Lewy bodies and Alzheimer's disease (2013) (0)
- IC-P-087 Annualized decrease in plasma Aβ42 correlates with annualized decrease in hippocampal volume (2006) (0)
- Antemortem MRI findings associated with presence of microinfarcts at autopsy (2013) (0)
- Multimodal imaging in familial FTLD: phenoconversion and planning for the future. (2019) (0)
- Diffusion tensor imaging characteristics of dementia with Lewy bodies and Alzheimer's disease (2009) (0)
- Objective home sleep profiles differentiate Alzheimer disease from α‐synucleinopathies (2021) (0)
- enzyme-linked immunosorbent NONLINEAR N-SCORE ESTIMATION FOR ESTABLISHING COGNITIVE NORMS FROM (2018) (0)
- EARLY-ONSET FRONTOTEMPORAL DEMENTIA IN A PATIENT WITH DUPLICATION OF EXON 15 OF THE MATR3 GENE (2019) (0)
- Anxiety is associated with mild cognitive impairment: The Mayo Clinic Study of Aging (2010) (0)
- Amyloid-β, Neuropsychiatric Symptoms and the Risk of Incident Mild Cognitive Impairment: A Prospective Cohort Study (S35.003) (2016) (0)
- Optimum differentiation of FTLD from AD achieved with cross‐sectional tau PET (2022) (0)
- Resting FDG-PET in neurologically normal individuals reporting dream enactment behavior: Preclinical dementia with lewy bodies? (2005) (0)
- CLINICAL CHARACTERIZATION OF MILD COGNITIVE IMPAIRMENT ASSOCIATED WITH EVENTUAL LEWY BODY DISEASE PATHOLOGY (2019) (0)
- PATHOLOGIC ASSOCIATIONS OF FDG PET IN LEWY BODY DISEASE (2019) (0)
- The aging brain: A cross-sectional resting state connectivity study (2010) (0)
- Development and Validation of a clinical scale for defining RBD severity in participants of the North American Prodromal Synucleinopathy (NAPS) consortium (2022) (0)
- 0268 Characterization of Neurodegenerative Disorder Subtypes Based on Non-REM Hypertonia and Sleep Spindle Duration (2022) (0)
- Saturday, March 17, 2007 (2007) (0)
- 1H MRS and hippocampal volumes predict risk of dementia in a population-based cohort: The mayo clinic study of aging (2009) (0)
- DIFFERENCES BETWEEN SPORADIC AND FAMILIAL BEHAVIORAL VARIANT FTD IN ADVANCING RESEARCH AND TREATMENT FOR FTLD (ARTFL) CLINICAL RESEARCH CONSORTIUM (2018) (0)
- MILD COGNITIVE IMPAIRMENT PROGRESSING TO DEMENTIA WITH LEWY BODIES: REGIONAL ATROPHY RATES AND RELATIONSHIP TO AV-1451 UPTAKE (2019) (0)
- Follow-up Supranuclear Palsy Features: 10-Year Case Report Mixed Corticobasal Degeneration and Progressive Long-Term Exercise Training for an Individual With (2016) (0)
- PREDICTORS AND PROTECTIVE FACTORS FOR COGNITIVE IMPAIRMENT IN VERY OLD COGNITIVELY NORMAL PERSONS (2014) (0)
- IC-P-144 PRINCIPAL AXES OF PHENOTYPIC VARIABILITY IN ALZHEIMER’S DISEASE DERIVED FROM AN FDG-PET BASED, UNSUPERVISED MACHINE LEARNING ALGORITHM (2018) (0)
- IMPAIRED SEGREGATION OF THE VENTRAL DEFAULT MODE NETWORK IN ALZHEIMER'S DISEASE (2014) (0)
- EEG biomarkers differentiate Lewy body dementia from Alzheimer’s disease (2021) (0)
- Presence of Microinfarcts at Autopsy is Associated with Increased Rate of Gray Matter Atrophy on Antemortem MRI (P4.017) (2014) (0)
- Age-related changes in the default mode network are more advanced in Alzheimer's disease (2011) (0)
- VARIABILITY IN PDMN CONNECTIVITY AND RELATIVE HUBNESS IN COGNITIVELY NORMAL INDIVIDUALS PREDICT AMYLOID AND TAU DEPOSITION PATTERNS IN TYPICAL ALZHEIMER’S DISEASE (2018) (0)
This paper list is powered by the following services:
